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SUMMARY
The use of behavioural models and electrophysiology are 
two commonly used approaches for studying the effects of 
the substance serotonin and serotonin-like drugs on the 
central nervous system.
The behavioural tests were developed following the 
discovery that pharmacological manipulations resulted in 
an increase in serotonin concentration in the central 
nervous system and led to the production of a definable 
behavioural syndrome. However, this is a gross measure 
of central serotoninergic interactions in the brain since 
it does not provide any information on the precise location 
of the cerebral regions involved.
The measurement of electrical activity has proved a 
powerful tool for directly measuring the functional 
activity of neurones and their responses to the micro- 
iontophoretic application of serotonin or serotonin- 
mimetic drugs. This technique is limited, in a practical 
sense, by the number of cells which can be measured in any 
one area of the brain and as an inevitable consequence of 
the use of anaesthesia in these preparations.
In recent years, a more direct measurement of regional 
cerebral function in the conscious rat has been developed. 
As glucose is the sole energy substrate for the brain under 
non-pathological conditions, its measurement is a direct 
index of cerebral function. The method in question uses 
- 2 deoxyglucose to measure local cerebral glucose 
utilisation by quantitative autoradiography. It provides, 
due to the unique properties of 2 deoxyglucose, a measure 
of the integrated response of the central nervous system
to pharmacological manipulation.
The results of this thesis are presented in four parts.
In the first, (Chapter III), serotonin, when administered 
into the carotid artery of halothane anaesthetised rats 
was found to have no effect on glucose utilisation unless 
the animal was first treated with the monoamine oxidase 
inhibitor, clorgyline. When these substances were 
combined, a number of regions were found to have decreased 
rates of glucose use, particularly in the cortex. The 
problem associated with this model will be discussed, 
particularly in relation to the depressive actions of 
halothane anaesthesia.
The second part (Chapters IV and V) of this thesis deals 
with the actions of two structurally-differing sets of 
putative serotonin agonists on the local cerebral glucose 
utilisation, behaviour and cardiovasculature of conscious 
rats. Lysergic acid diethylamide and 5 methoxy-lT,N-dim- 
ethyltryptamine both contain indeleamine portions to their 
structures; as does serotonin itself. Quipazine and 
chloropiperazinylpyrazine contain piperazine moeities 
which make them structurally similar to tricyclic anti­
depressants.
In the majority of brain areas studied, these two sets of 
putative serotonin agonists produced a depression in glucose 
use; and therefore function. However, in a select number 
of structures in the anterior thalamus and in some 
extrapyramidal areas, the piperazine-containing compounds 
were capable of producing significant increases in glucose 
use. A pattern quite different from that produced by the
indoleamine containing substances.
The third section (Chapter VI) deals with the use of 
substances which have been suggested as serotonin 
antagonists in the central nervous system. These compounds, 
metergoline, methysergide and cyproheptadine, have all been 
shown to be potent antagonists at serotonin receptors in 
the periphery. In the present experiments they were found 
to produce decreases in local cerebral glucose utilisation 
at relatively high doses. These results have implications 
with regard to the "classical" concept of receptor antag­
onists .
In the final section of results, (Chapters VII and VIII) 
data are provided on the actions of the four putative 
serotonin agonists following the pretreatment of metergoline 
and methysergide. The consequence of this combination of 
treatment was that some but not all agonist effects were 
inhibited. On the contrary, in certain cerebral areas the 
functional response to the serotonin agonist was either 
unaffected or potentiated by the pretreatment of metergoline 
or methysergide. Thus, the combination of "agonist" and 
"antagonist" produced a pattern of response which was very 
different from that produced by either set of compounds 
alone.
In the subsequent discussion a synthesis of this information 
is attempted in the light of previous in vivo and in vitro 
information.
PREFACE AND DECLARATION.
The biogenic amine serotonin (5 hydroxytryptamine) is 
a strong candidate as a central neurotransmitter and 
may well be involved in a number of diverse physiological 
mechanisms such as sleep, behaviour, mood and the control 
of hormonal secretion from the pituitary.
This thesis deals with the anatomical location of functional 
changes, as measured by local cerebral glucose utilisation, 
in brain regions sensitive to pharmacological manipulation 
by serotonin - mimetic drugs.
The data was obtained from my own original experiments.
This material has not been presented as a thesis in any 
form.
I. INTRODUCTION.
Serotonin has been implicated in a diverse number of 
physiological functions in the central nervous system 
such as overt behaviour, (Aprison et al, 1975; Gibbons 
and Glusman, 1979; Marks et al, 1978; Meyerson et al,
1978 inter a l i a )  anorexia (Blundell, 1977 for review; 
Clineschmidt et al, 1978; Garattini and Samanin, 1978; 
Samanin et al, 1980), analgesia (Messing and Lytle, 1977; 
Yaksh, 1979;' York and Maynert, 1978), sleep (Koella et 
al, 1968; Jouvet, 1969; Jouvet 1972) and the regulation 
of the hypothalamic/pituitary axis. (Fuller et al, 1976; 
Krulich, 1979; Meltzer et al, 1978), A role for serotonin 
in the etiology of mental depression has also been suggested. 
(Asberg et al, 1973; Murphy et al, 1978; Van Praag and 
Korf, 1974). Given this diverse functional involvement 
it is of vital importance to obtain data on the effects of 
perturbation of the central serotonin system on cerebral 
function in order that the modulatory role of this substance 
can be better understood. I shall first consider the 
information which is available on serotonin in the central 
nervous system.
1.1 Historical Perspective:
Lesions of the median forebrain bundle produced a depletion 
of 5HT in the forebrain which paralleled the degeneration of 
the neurones. (Heller et al, 1962 ; Heller and Moore, I965) 
This indirect evidence was further supported by the direct 
visualisation of the fluorescent products of serotonin 
produced by the formaldehyde-oondensation histochemical
method of Falk et al (1962). This allowed the mapping of 
neuronal cell-bodies (Dahlstrom and Fuxe, 1965), terminals 
(Aghajanian et al, 1973; Fuxe, 1965) and pathways (Anden 
et al, 1966). The cell-bodies were found to be mainly located 
within the brainstem raphe nuclei. Nine nuclei were 
identified and these were designated B1 - B9 (Fig. 1).
These perikarya send projections to the spinal cord, 
brainstem and to much of the forebrain (Fig. 1), The central 
nervous system also contains all the biochemical apparatus 
necessary for the synthesis, storage and inactivation of 
5HT. (see below and legend to figure 2).
The destruction of the serotonergic cell-bodies leads to 
a degeneration of histochemically identifiable 5HT terminals 
in the forebrain. (Aghajanian, 1969; Kuhar efc al, 1972)
There is a.lso an anatomically selective reduction in 5HT 
contento (Heller and Moore, 1965; Kostowski et al, 1968; 
Jacobs et al, 1974; Balkovits, 1977) as well as a selective 
decrease in forebrain tryptorhan hydroxylase activity 
(Kuhar et al, 1971; Balkovits, 1977)* Midbrain raphe 
lesioning also affected the uptake of serotonin into 
synaptosomes which were subsequently formed from the 
forebrain. (Kuhar et al, 1972) stimulation of the 
mid brain raphe nuclei produces increased synthesis and 
turnover of 5HT in the forebrain (Kostowski et al, 1969; 
Bheerd and Aghajanian, 1968 : Shields and Eccleston, 1972)
Furthermore, a variety of sensory stimuli increase the 
release of endogenously produced 5HT and the activity of the 
raphe nuclei. (Aghajamian et al, 1978; Jacobs et al, 1980; 
Le Moal et al, 1979; Trulson et al, 1979; Reisine et al, 
1982.)
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This brief resume is enough to suggest that serotonin 
is a neurotransmitter in the central nervous system of 
the rat. The biochemistry, anatomy and electrophysiology 
of the serotonergic system in the rat forebrain will now 
be studied in more detail.
I. 2 Serotonin Metabolism in the C.N.So
The substrate for serotonin synthesis^ the naturally 
occurring amino acid 1,-tryptophan, enters the brain via a 
transport mechanism for neutral amino acids. (Pernstrom 
and V/urtman, 1972). In vitro studies have shown that a 
similar mechanism regulates the entry of the L-tryptophan 
into the serotonergic neurone. (Grahame-Smith and Parfitt, 
1970; Parfitt and G rahame-Smith, 1974.) Once inside the 
cell it becomes the substrate for the enzyme tryptophan 
hydroxylase which produces 5-hydroxytryptophan as a product. 
This is the rate-limiting step for 5HT synthesis in the brain 
(Green and Grahame-Smith, 1975). The Km for tryptophan (in 
the presense of biopterin H^;BH^) is almost equal to the 
G.N.S. tissue level of tryptophan. Under these conditions 
increasing the L-tryptophan levels may result in an inhibition 
of tryptophan hydroxylase activity. (Azmitia and McEv/an, 1974; 
Preidman et al, 1972; Knapp and Mandel, 1973.) (Pig. 2)
Once synthesised 5HTP is almost immediately decarboxylated 
to yield serotonin. The enzyme responsible, 5 - 
hydroxytryptorhan decarboxylase, is similar to the enzyme 
which decarboxylates dihydroxyphenylalanine. The serotonin 












Figure 2 I .The enzyme tryptophan hydroxylase - the rate-
limiting enzyme of 5HT synthesis. 2. 5HT after synthesis 
is stored in vesicles. 3. The propagation of an action 
potential to the synapse leads to the release of 5HTo 
4o Post-synaptic 5HT receptor. 5o Uptake back into the 
synapse by high-affinity uptake system* 5HT is taken up 
by vesicles or is inactivated by monoamine oxidase. (MA.O) 
(Modified from Cooper et al, 1978).
of the neurotransmitter reduce the activity of tryptophan 
hydroxylaseo (Hamon et al, 1973; Carlsson and hindquist,
1973» and Hamon and G-lowinski, 1974 for review.)
The major route of catabolism for serotonin is deamination 
by the enzyme monoamine oxidaseo Different forms of this 
enzyme have been demonstrated in vivo and in vitroo (Sandler 
and Youdira, 1972) Using clorgyline Johnston (1968) 
distinguished between "Type A" and "Type B" monoamine 
oxidase enzymes « Type A deaminates serotonin as well as 
noradrenaline and dopamine* (Sandler and Youdim 1974;
Houslay and Tipton, 1974). This enzyme deaminates serotonin 
to form 3 hydroxyindoleacetaldehyde which can be further 
catabolised to 5 hydroxyindoleacetic acid or 5 
hydroxytryptophal by aldehyde dehydrogenase and alcohol 
dehydrogenase respectively. (See Sandler and Youdim, 1972 
for review.)
The rate of turnover of serotonin is an important biochemical 
method of assessing the activity of serotonin systems*
However, such changes have to be treated with caution since 
large doses cf tryptophan, which clearly increase brain 5HT 
turnover, produced no behavioural effects* (G-rahame-Smith, 
1971). Following monoamine oxidase inhibition (Grahame- 
Smith, 1974) a vivid behavioural syndrome was observed.
Thus, the brain has ^11 the necessary mechanisms to enable it 
to rapidly synthesise and catabolise serotonin* How is 
serotonin distributed in the brain?
I. 3 Anatomy of Serotonin Systems in the Forebrain of the Rat 
The bulk of the information given in this thesis concerns the
actions of putative 5HT agonists and antagonists on the 
function of the cerebellum, hindbrain and forebrain. These 
are the only areas which will be covered by the present 
discussion, although the spinal cord does receive a heavy 
innervation by serotonergic processes arising in medullary 
nuclei. (Dahlstrom and Fuxe, 1965; Zivin et al, 1975),
I. 3 .I0 Serotonin-Containing Gell-Bodies: The majority of 
serotonergic fibers innervating the forebrain arise from cell- 
bodies within the dorsal and median raphe nuclei (Azmitia and 
Segal, 1978; Chan-Palay, 1977; Steinbusch, 1981; Takeuchi 
et al, 1982.) and an area just outside the median raphe nucleus 
and lying laterally to it « These clusters of cells correspond 
with the cell groups described by Dahlstrom arid Puxe, 1964 
and as B7 , B8 and B9 respectivelyo (Pigo 1 ).
As well as these locations, there is evidence of serotonin- 
containing cell-bodies in the periventricular and paravent­
ricular nuclei of the hypothalamus, the suprachiasmatic 
nucleus and the medial habenular nucleus (Chan-Palay, 1977.)
However, it has been suggested that the latter results are a
%
technical artifact due to the uptake of H-serotonin by 
dopaminergic processes in these areaso (Steinbusch, I98I)
I. 3.2. Cortical Areas: Previous investigators have found
that the raphe nuclei project to all areas of the cortex 
(Azmitia and Segal, 1978) and that these areas can be shown 
to have a diffuse system of serotonergic nerve-endingso 
(Chan-Palay, 1977; Steinbusch, 1981). It is interesting to 
note that there is evidence of differential, although
overlapping fields of cortical innervation arising from 
the dorsal and median raphe nuclei (Azmitia and Segal, 1978). 
The dorsal raphe nucleus seems to project mainly to the 
temporal, parietal and pyriform corticeso The median 
raphe nucleus projects mainly to frontal, cingulate and 
entorhinal cortices.
I. 3.3 Diencephalic Areas: One means of differentiating
the thalamic nuclei is by means of their projections* 
(Donaldson et al, 1975 )o Under this criterion the 'specific’ 
thalamic nuclei are those which project to layer IV of the 
cortex. These nuclei make up the majority of the thalamic 
mass in the rat. (Donaldson, 1975; Jasper, 1961)*
The second group are the non-specific thalamic nuclei which,
although fewer in number, have diverse connections with 
cortex, other thalamic and subthalamic areas, and other 
sub-cortical areas (Herlenham, 1978; Schlebel and üchiebel, 
1967)0 The pertinence of this nomenclature is that the 
serotonergic fibers arising from the midbrain raphe nuclei 
innervate most heavily the 'non-specific' thalamic nuclei 
such as the nucleus reunions (Azmitia and Segal, 1978; 
Steinbusch, 1981) with the possible exception of the lateral 
thalamic nucleus (Chan-Palay, 1977; Steinbusch, 1981 )o 
bnithalamic areas such as the medial and lateral h^benula 
receive substantia] inputs from the dorsal and median ranhc 
nuclei (Azmitia and begal, 1978; Chan-Palay, 1977; 
Steinbusch, 1981). Most of the hypothalamic nuclei receive 
serotonergic fibers from raphe nuclei; in particular the 
sunrachiasmstio nud eus, the ^rcuate nucleus, the
periventricular nucleus and paraventricular nucleus* 
(Chan-Palay, 1977: Saavedra et al, 1974B, Van de Kar
and Lorens, 1979).
I. 3*4 Limbic Areas : The term 'limbic' is functional
rather than anatomical. It forms an Integrated system 
which is involved in a great number of autonomic and 
viceral functions and in the regulation of behaviour.
(MacLean, 1954). Por the uurposes of this thesis I 
shall concentrate on the serotonergic inputs into the 
limbic cortex (pyriform, entorhinal and cingulate cortices) 
and its sub-cortical regions; the hicpocampal formation, 
septal nuclei, amygdaloid nuclei, ventral tegmental area 
and the nucleus accumbens.
The limbic cortical areas all receive a serotonergic input 
arising in the midbrain raphe nuclei* (Azmitia and Segal, 
1978; Beckstead, 1978; Kohler et al, 1980: Segal, 1977)=
The hippocampal formation is innervated mainly bp the raphe 
nucleus but it also receives inputs from the dorsal raphe 
nucleus (Azmitia, 1981; Azmitia and Segal, 1978; Moore 
and Halarrs, 1975), One of the serotonergic pathways from 
the raphe nuclei innervates the dentate gyrus via the 
perforant pathway which runs from the entorhinal cortex 
to the molecular layer of dentate gyrus. (Azmitia and Segal, 
1978; Hjort-Simonsen and Jeuve, 1972; Srebro et al, 1982). 
Another major pathway travels via the cingulate cortex. 
(Azmitia and Segal, 1978; Moore and Halaris, 1975). Fibers 
from this pathway innervate the septal nuclei and nucleus 
accumbens in passage. The amygdaloid nuclei receive 
innervation from serotonergic fibers oarticularly the medial 
nucleus and anterior amygdaloid area* (Azmitia and Segal 197P 
Steinbusch, 1981).
lo 3o5 Extrapyramidal Areas: As with the limbic system,
the term extrapyramidal cannot be wholly defined anatomically. 
However, it has become synonymous with the caudate nucleus, 
globus pallidus, substantia nigra and subthalamic nucleus* 
(Nauta and Domesick, 1979). All of these areas receive 
innervation from the midbrain raphe nuclei, particularly the 
dorsal raphe nucleus. (Azmitia, 1978; Bunney and 
Aghajamian, 1978; Miller et al, 1975; Steinbusch, 1981; 
Ternaux et al, 1977). An interesting finding based on 
both anatomical and biochemical evidence is that the 
distribution of the serotonergic innervation of the caudate 
nucleus is uneven. The ventromedial and caudal areas of 
this structure are much more heavily innervated than the 
dorsolateral or central portions. (Euvrard et al, 1977; 
Guyanet et al, 1977; Ternaux et al, 1977; Vizi et al, 1981). 
As will become evident from the results and discussion 
sections of this thesis, interesting comparisons can be 
made between the anatomical innervation of the forebrain by 
serotonergic neurons and the changes in local cerebral 
function following the pharmacological manipulation of the 
central serotonin mechanisms. However, how does the 
serotonin present in the neuronal endings interact with 
the cellular processes in close proximity to it^to produce 
a physiological response?
I. 4 Central berotonin Receptors
Numerous attempts have been made to define the 5HT receptor 
populations in the rat brain, using H-5HT (Bennet and 
Snyder, 1976; Billion et al, 1978; Nelson et al, 1980 a.b.) 
^H-L.S.D. (Bennet and Snyder, 1976; Pillion et al, 1978;
Love and Preedman, 1978), ^H-Suiroperidal (only in the 
cerebral cortex and hippocampus) (Creese and Snyder, 1978; 
Leysen et al, 1978) and ^H-metergoline (Hamon et al, 1981)* 
Known agonists and antagonists of serotonin are potent 
aisplacers of these tritiated compounds * (Bennet and 
Snyder, 1976; Creese and Snyder, 1978; Pillion et al, 1978; 
Lovell and Freedman, 1975; Nelson et al 1978; Nelson et al, 
1980; Nelson et al, 1981; Peroutka and Snyder, 1979)°
The postsynaptic location of these binding sites was 
confirmed when selective lesioning of the serotonergic 
neurons failed to modify the kinetic parameters of the 
tritiated ligands (Bennet and Snyder, 1976; Pillion et al, 
1978, Hamon et al, 1981).
There is little stimulation by 5HT of the synthesis of 
cyclic adenosine monophosphate (cAMp) from ATP in crude 
membrane preparations from the brain of adult rats but 
the activity of adenylate cyclase doubles in cell-free 
extracts from new-born rats (Enjalbert et al, 1978; Von 
Hungen et al, 1975)° In young animals then, there is good 
evidence thrt this 5 uT - sensitive adenylate cyclase is 
coupled to specific post-synaptic serotonin receptors, 
(Bourgoin et al, 1977 a = b * Enjalbert et al, 1978 a.b*
Nelson et al, 1980 a.b* Von Hungen et al, 1975)°
Are there any differences to be found between bindina sites 
bound by the ligands?
It was found t lat H-srironeridal bound strongly to
specific sites in the frontal cortex and hiprocampus. At
3these sites the binding of H-spiroperidal was inhibited 
more by serotonin-active drugs than dopamine agonists and
iz
antagonists* (Creese and Snyder, 1978; Lysen et al, 1978; 
Palacios et al, 1981; Pedigo et al, 1981; Seeman et al,
1980). It was also found that known serotonin agonists
such as 5“HT, 5 Methoxy -N,N-dimethyltryptarnine and quipazine
3 3were much more potent at displacing H-5HÏ than H-
spiroperidol (in frontal cortex and hippocampus)* However,
serotonin antagonists such as methiothepin, metergoline,
cyproheptadine, methysergide and mianserin inhibited
3 3-^H-spiroperidol binding better than H-5HT binding*
(Nelson et aï, 1979; Nelson et al, 1980 a*)* These
findings have been confirmed by using H-metergoline to
bind to the 'antagonist' site* (Hamon et al, 1981)*
3 3It cannot be concluded however, that H-5HT and H-
spiroperidol bind to two different 5HT receptors* The
binding site may well exist in multiple interconverting
forms* If this were the ca.se then the regional distribution 
3 3of H-5HT and H-spiroperidol sites should be the same*
In the hippocampus, there is a close relationship between
3 3the number of specific binding sites for 'H-5HT, H-
spiroperidol and 'H-metergoline. (Creese and Snyder, 1978;
Hamon et al, 1981; Nelson et al, 1978)* The subcellular
3 3distribution of H-5HT and H-spiroperidol were also very 
closely linked in adult rats. (Hamon et al, 1980). Thus, 
this evidence is suggestive of a single receptor existing 
in different conformational attitudes*
However, there are differences in the pharmacological profiles.
Metergoline blocks ^H-5HT binding to a much greater extent 
%
than H-spiroperidol (Nelson at al, 1978)* Furthermore, 
quipazine is much less potent than 5HT at displacing ^H-5HT,
3but much more potent than 5HT at inhibiting H-
spiroperidol binding* (Hamon et al, 1980; Ouik et al,
1978). Thus, the question is not totally resolved and
further experiments will be required before the problem,
3 3of whether or not H-5HT and ^H-spiroperidol bind to the 
same or different sets of 5HT receptors,can be adequately 
resolved,
3What similarities, if any, are there between H-5HT and 
3H-spiroperidol binding sites, and the 5HT- sensitive 
adenylate cyclase found in young rats? Several serotonin 
agonists (5 methoxy-N,N-dimethyltryptamine, L.S.D., 
bufotenine) stimulate 5HT-sensitive adenylate cyclase*
(Von Hungen et al, 1975 )= The 5HT-sensitive adenylate 
cyclase is located on post-synaptic membranes since 
midbrain raphe lesioning did not alter the enzymatic 
response* (Bourgoin et al, 1977)°
The binding of 3H-5HT increased by more than 250?o between 
the 1st week and the 3nd month after birth in the 
hippocampus and the striatum but the activity of the 5HT- 
sensitive adenylate cyclase did not change significantly* 
(Hamon et al, 1980; Nelson et al, 1980b)* Furthermore, 
serotonin agonists with a piperazine group (quipazine,
1 (m-trIfluoromethylphenyl)-piperazlne and 6 chloro 2- 
[l-piperazinyl] pyrazine were potent displacers of ^H-5HT 
but neither stimulated nor inhibited 5HT sensitive adenylate 
cyclase. (Fuller et al, 1978; Nelson et al, 1980a)* Therefor 
it is difficult to conclude that the ^H-5HT binding site is 
associated with the 5HT-sensitive adenylate cyclase*
In a similar fashion, quirazine which fails to stimulate
the 5HT- sensitive adenylate cyclase was a potent 
inhibitor of H-spiroperidol binding (Hamon et al,
1980)* Metergoline is almost equally as potent as 
spiroperidol in blocking 5HT-sensitive adenylate cyclase 
stimulation by 5HT, but is 100 times weaker than this 
compound in displacing bound 'H-spiroperidol (Hamon et al, 
1980)* Thus, it would seem unlikely from this evidence 
that ^H-5HT or ^H-spiroperidol are identical to the 5HT 
receptor site which is coupled to adenylate cyclase in 
membranes of tissues from young rats*
Pfowever, the nucleotide, guanosine triphosphate (G.T.P.)
3
reduces the specific binding of 'H-5HT to cell membranes, 
in adult and 1 week-old rats * (Hamon et al, 1980; Mallat 
and Hamon, 1982), Conversely, G.T.P. does not alter
3
H-spiroperidol binding in the caudate nucleus, cerebral 
cortex and hippocampus. (Hamon et al, 1980)* Puthermore,
3
the ability of 5HT to displace H-spiroperidnl was markedly 
reduced by the presence of G.T.P. (Hamon et al, 1980).
This data suggests that 5HT can act as an agonist at some 
receptors binding 3H-snironeridol. The presence of G.T.P. 
also reduced the potency of 5 methoxy-N,N-dimethyltryptamine
3
displacement of H-spiroperidol, but had no effect on the 
actions of quipazine i.e. the agonists that displace less
3
'H-spiroperidol are those which stimulate adenylate cyclase 
(5HT and 5 methoxy-N,N-diraethyltryptamine)* (Hamon et al, 
1980) o However GTP potentiated the effects of 5HT on adenylate 
cyclase. This apparently opposite action of G.T.P, on 
5HT binding and 5HT-sensitive adenylate cyclase activity 
might however, be explained by the recent findings of Mallat
and Hamon, 1982a.) They found that Kainic acid lesioning (a
compound which destroys cell-hodies but not fibers of
passage) led to a. marked reduction in the effects of
G.T.P. on the suriving 'H-5HT binding* This suggests
3that the population of receptors binding H-5HT is 
heterogeneous and that some of the H-5HT binding sites 
may be coupled with adenylate cyclase. They also found 
that the pattern of 'H-G.ToP* binding corresponded to the 
G.T.P, subunits regulating adenylate cyclase activity 
including those binding ^H-hHT* (Mallat and Ramon, lG82b.)
Tn conclusion, there is reasonable evidence of multiple 
serotonin receptors in the central nervous system* Whether 
these are di^Terent receptor populations or intecconverting 
forms of the same set of serotonin receptors is unclear.
In young rats, 5HT is capable of stimulating adenylate 
cyclase activity* There are differences in the way 
serotonin agonists which have piperazine and indoleamine
3 -X
moeties bind to ■H-5HT and ^H-spiroperidol bindinv sites 
(in the presence of G.T.P.) and to 5HT receptors coupled 
with adenylate cyclase*
The major problem however with this data is th'^ t much 
of it stems from in vitro work* Thus, there is no means 
of ascertaining the physiological role of these receptors.
1. 5 The Hourophysiology of the Serotonin-Containing lieui'ons 
We have now seen that serotonin in the central nervous 
system is contained within neuronal r,recesses which 
innervate anatomically discrete areas of the rat brain*
There are also specific recentors for serotonin but what
physiological effect does the interaction of neuronally 
released serotonin have following combination with serotonin 
receptors?
In a study on the anaesthetised rat Aghajanian, 1972, 
showed that the firing rate of raphe neurons was between 
Oo5 and 2*5 spikes/sec* A similar range of neuronal firing 
is found in the conscious cat, 0 * 5 - 5  spikes/sec. (McGinty 
and Harper, 1976)* This is very slow when compared to cells 
which form part of the reticular formation* These fire at 
a rate of 100 - 300 spikes/sec* (Ozerb, 1967).
Serotonergic axons can be identified using the intracere- 
broventricular administration of ^H-5HT (Aghajanian and 
Bloom, 1967; Aghajanian et al, 1966). The axons labelled 
by ^H-5HT were found to be fine and unmyelinated in type* 
Using antidromic stimulation of the ventral tegmentum, it 
was found that their conduction velocity was of the order of 
0*5 - 1.5 m/sec* which is a relatively slow conduction 
velocity (Aghajanian and Wang, 1977),
lontophoretically applied 5HT had an inhibitory effect on 
cell-firing rate on most cells tested* (Bloom et al, 1972)* 
When 5HT itself or the 5HT mimetic substances, lysergic acid 
diethylamide (L.S.D.) and 5 methoxy-N,N-dimethyltryptamine 
(5MeO) are injected iontophoretically into the dorsal raphe 
nucleus they cause an inhibition of firing rate* (Aghajanian 
et al, 1972; Bramwell and G-onye, 1976; de Montagny and 
Aghajanian, 1977). This would suggest the presence of 
a 5HT receptor which is an autoreceptor (i.e. a receptor 
mediating the response of a neuron to its own neurotrans­
mitter ).
In the forebrain, the effects of microiontophoretically
administered 5HT have been tested on the firing rate of 
cells in a number of anatomically diverse areas; the 
amygdala (Wang and Aghajanian, 1977), the ventrolateral 
geniculate (Haigler and Aghajanian, 1974), the hippocampus 
(Segal, 1975; S e g a l 1976) the cerebral cortex (Sastry 
and Phillis, 1977) the corpus striatum (Olpe and Koella, 
1977) substantia nigra (Dray et al, 1976) and cerebellum 
(Strahlendorf et al, 1979)°
In the hindbrain, iontopheretic 5HT causes an increase in 
firing rate in the brain stem reticular formation 
(Aghajanian et al, 1974; Aghajanian and Wang, 1978;
Bloom et al, 1973; Bradley and Wolstencroft, 1965) and 
in the motoneurones of the facial nerve (McCall and 
Aghajanian, 1979; Van derMaelen and Aghajanian, 1980).
In these latter cases the effects of 5HT were blocked by 
peripheral serotonin antagonists (e.g* methysergide)* 
However, this is not always the case with the inhibitory 
responses of cells to 5HT administration. (Aghajanian 
and Wang, 1978; Haigler and Aghajanian, 1974; Wang and 
Aghajanian, 1977)*
These observations suggest that there are at least two 
types of physiological receptor for 5HT in the central 
nervous system. The first mediates a depression in cell- 
firing rate and is not always blocked effectively by 
classical 5HT antagonists* The second appears to mediate 
a 5HT-induced excitation in cell-firing and is antagonised 
by methysergide and cyproheptadine* This latter in effect 
may not be the result of a direct interaction of 5HT with 
its receptor but may be a facilitation of excitatory inputs 
(McCall and Aghajanian, 1979)°
This electrophysiological data suggests that the main 
effect of 5HT in a diverse number of cerebral areas is 
to produce an inhibition of cell-firing* It is capable, 
however, of producing an excitatory response* This latter 
is most clearly antagonised by methysergide and cyprohep­
tadine, the former less consistently*
There are, however, problems in interpreting the data 
obtained from these experiments particularly with respect 
to other in vivo approaches (e.g* behavioural studies*) 
Firstly, the micriontopheretic technique only allows a 
small number of cells to be tested* Secondly, it gives 
no indication of what the integrated functional response 
of the brain would be when a drug is administered by a 
peripheral route* Thirdly, it is a normal prerequisite of 
this experimental approach for the animal to be anaesthetised 
This, as we shall see, may be of particular importance 
when studying cerebral function (See Grome and McGulloch,
1981 a.b.; Grome and McGulloch, 1983, and this thesis*)
I. 6. The Value of the 2-Deoxyglucose Method 
Since its introduction (Sokoloff et al, 1977), the '^^ G 
2 deoxyglucose quantitative autoradiographic method has 
become widely used to measure the effects of physiological, 
pharmacological and pathological manipulations on cerebral 
function as measured by local cerebral glucose utilisation* 
(For examples see Discussion and Synthesis section of this 
thesis).
Its main advantages over other available technology are 
that it can be used in both conscious and anaesthetised 
animals; that it allows both the precise anatomical
localisation of changes in cerebral function and by 
comparing these effects, the integrated functional response 
of a group of anatomically connected structures*
For these reasons it provides new information which could 
not be obtained in any other v/ay at the present time.
For the work about to be presented, the fully quantitative 
2 deoxyglucose method, as devised by Sokoloff and his 
colleagues, 1977, was used throughout and so, in the 
following sections of this thesis, data will be provided 
on the actions of 5HT itself, putative 5HT-mimetic drugs 
(L.S.D., 5 methoxy-N,N-dimethyltryptamine, quipazine and 
chloropiperazinylpyrazine) and putative 5HT antagonists 
(methysergide, metergoline and cyproheptadine) on local 
cerebral glucose utilisation, a direct measurement of 
cerebral function* (Fig* 3)
Figure 3 Structures of drugs used in this study,
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IIo MATERIALS k m  METHODS 
2o 1. Background to the deoxyglucose method.
There are major problems when faced with the task of 
measuring the functional activity of the central nervous 
système The subunits which integrate to form the functional 
networks of the brain are anatomically discrete and subserve 
physiologically diverse roles* Furthermore, the central 
nervous system is constantly reacting to the input it 
receives0 Therefore, any method purporting to define 
brain activity should ideally be able to make dynamic 
measurements of both local and integrated function*
In a similar manner to heart and skeletal muscle, it 
has been found that there is a close relationship 
between the activity of the brain tissue and the quantity 
of energy substrates which it consumes* (De Weer, 1975; 
G-reengard and Ritchie, 1971; Ritchie, 1967 )*
Since under non-pathological conditions the central 
nervous system meets all its energy demands by the 
oxidative catabolism of glucose, (see Sokoloff, I960), 
it might be supposed that the measurement of the rate of 
glucose or oxygen use would be an effective way of 
calculating functional activity* The direct measurement 
of these parameters is unfortunately fraught with 
difficulty. The level of oxygen content and its 
turnover can be measured by oxygen electrodes (Greengard 
and Ritchie, 1971; Ritchie, 1967)0 However this technique 
has similar
problems to thut of the electrophysiological 
measurement of cell-firing rate, (see previous section) 
The measurement of turnover^^isotopes of oxygen is also 
difficult due to their short half-lifes, and they are 
rapidly cleared from the cerebral tissue*
This latter problem a,Iso applies to the use of ^^0- 
glucose to measure cerebral functional activity* Sacks, 
1957 showed that significant concentrations of GO^ were 
lost within two minutes of commencing the experiment* 
This leads to an underestimate of glucose utilisation. 
(Hawkins et al, 1974)
These problems have been largely overcome by the use of 
^^ 'G~2 deoxyglucose; an analogue of glucose*
2 * 2 2 Deoxyglucose
The molecule 2-deoxyglucose differs from glucose only in 
as much as the hydroxyl gi'oup on the second carbon has been 
replaced by hydrogen* This single change produces a number 
of interesting metabolic features* Firstly, it is 
transported between the blood and brain by the same hexose 
transport mechanism as glucose* (Bidder, 1968; Horton et 
al, 1973)0 Secondly, 2 deoxyglucose and glucose are 
substrates for the enzyme hexokinase which phosphorylates 
them to 2 deoxyglucose- 6-phosphate and glucose-6-phosphate 
respectively (Sols and Crane, 1934), Thirdly, and most 
important of all, 2 deoxyglucose 6 phosphate, unlike 
glucose 6 phosphate is not a substrate for phosphohexose- 
isoraerase* Nor does 2 deoxyglucose 6-phosphate seem to 
be a substrate,for any other metabolic pathway* (Sols and
Crane, 1954; Bachelard et al, 1971; Horton et al,
1973). Deoxyglucose 6 phosphate can be broken down 
to deoxyglucose by glucose-6-phosphatase* However, 
the concentration of this enzyme is reported to be 
very low in mammalian brain. (Ruggi et al, I96O;
I'rasannan and Subrahmayan, 1968). Although this poses 
a theoretical problem, in practice it can be 
minimised* Thus, the 2 deoxyglucose-6-phosphate formed 
is trapped intracellularly and the concentration of this 
substance increases at a rate which is directly related 
to the phosphorylation of glucose which in turn is 
controlled directly by the rate of glucose utilisation*
2 0 3 Theoretical Model
The model is based on the unique biochemical 'personality* 
of 2 deoxyglucose as described in the previous section*
The theoretical model is diagrammatically presented in 
fig* 4o It can be seen that 2 deoxyglucose and
glucose enter the brain from the plasma via a common 
carrier in the blood-brain barrier* Once in the brain, 
these two compounds enter a common precursor pool in 
which they compete for either the carrier, to be 
transported back to plasma, or the enzyme to be 
phosphorylated to their respective hexose 6 phosrhates* 
The hexokinase reaction is far from equilibrium and since 
'^'^C deoxyglucose 6 phosphate is unable to take p^rt in 
any known metabolic process, it is trapped within the cell*
4^-


















Figure 4 Representation of the theoretical model for the 
2 deoxyglucose (2DG) technique.
Where: Gi* - total ^ ^G concentration in tissue*
G^* and G^ - precursor pool concentrations of 2DG 
and glucose*
“ concentration of 2DG-6-P in tissue.
Ki*, K^* and - rate constants for 2DG transport
from plasma to brain, brain to
plasma and its use by hexokinase
respectively.
K^, Kg and K^ - respective rate constants for glucose
(for further explanation see Sokoloff,
1977.)
Glucose-6-phosphate does not accumulate, and is 
eventually metabolised to carbon dioxide and water
2 o 4 Assumptions and Conditions of the Model
1. deoxyglucose and deoxyglucose 6 phosphate
are present in tracer amounts*
2*, Free deoxyglucose and glucose are in n single
compartment,
3, Carbohydrate metabolism in the brain is in steady state*
144<> The capillary concentrations of C deoxyglucose and 
glucose are approximately equal to their arterial plasma 
concentrations *
2 * 5. Explanation of Operational Equation
The operational equation is illustrated in fig* 5o The
equation may look complex but in effect it is simply a
mathematical statement of the requirements of the method*
In other words, in order to quantify the amount of glucose
consumed by an area of cerebral tissue, we measure the
amount of labelled products formed during the experimental
period* The quantity of labelled rroduct still in the 
14form of ^0 deoxyglucose is subtracted from this and. the 
remainder is divided l>y a lumped constant (which is a value 
exrrecsinr the differences in kinetics and distribution 
of deoxymluocse and glucose) multiplied by the irtegral 
of the pla.sma history for deoxyglucose and glucose
during the experimental period which is corrected for the 
lag time of equilibration*
V,, v-M icMi ui ix cu u iiu n  txaies WITH I ra ce rs  :
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Figure 5. Operational equation of the ^^0 - 2DG methodo
Where: C^* - total concentration.in tissue*
T - time at termination of experiment.
Cp* and Cp - plasma 2DG and glucose concentrations.
K * Kg*; K^* - rate constants for 2DG transport from
 ^ ' 2 5 plasma to brain, brain to plasma and
its use by hexokinase respectively.
K^, Kg, K^ - respective rate constants for glucose.
X - the ratio of the distribution space of 2DG 
in the tissue to that of glucose.
Æ  - fraction of glucose that, once phosphorylaiec
^  continues down glycolytic pathway.
K * and V *- Michaelis-Menton Kinetic constants for 2DG. 
m m
K and V - Kinetic constants for glucose, 
m m
These last four sets of constants make up the 'lumped' 
constant. (Modified from Sokoloff et al, 1977).
2 o 60 Values of Hate Constants and the Dunned Constant.
The rnte constants and lumped constants relating to the 
operational equation of the method (Fig 5) were obtained 
from Sokoloff et al, 1977*
For the albino rat, they are as follows 
K 1* - 0,189 (min .
K 2* - 0,245 ( m i n . ,
K 3* - 0,052 (min .
’Lumped Constant’ - 0,481,
Full details pertaining to the use of these constants, 
with particular reference to the errors involved have 
been previously published. (Sokoloff et al, 1977; 
Sokoloff, 1979; Sokoloff, 1982),
2, 7. Animal Préparation
Male Sprague-Dawley rats (300g-450g), which were allowed 
free access to food and water until the day of the 
experiment, were used throughout these studies.
Two preparations were used: -
2o 7, 1 Anaesthetised rats for the study of the 
intracarotid administration of drugs.
For these studies, ra.ts were initially anaesthetised 
with 5fô halothane in a mixture of nitrous oxide and oxygen 
(704;h30/b)* The rat had a cannulainserted into the trachea 
and was mechanically ventilat'-^d with a positive pressure, 
pump (Starling). . The halothane concentration vns then 
reduced to 0,5% and, under this anaesthetic regime, 
polyethylene catheters were placed into the femoral 
artery and vein, of each hindlimb. The skin on the rimht 
side of the neck was retracted in order to expose the
carotid artery, A cannula was placed retrogradely 
into the external carotid artery such that the tip 
lay at the bifurcation of the internal and external 
carotid arteries, Tennerature was maintained by a 
heating bed which was regulated by a rectal thermometer 
to keep the core temperature in the range 36,8^0 to 
37o2^C. The rats were then left for a period of not 
less than 4-5 minutes to allow the animal to stabilise,
2*7.2* Conscious rats for the study of the intravenous 
administration of drugs.
Anaesthesia was induced as above* Under light 
halothane anaesthesia (1^ halothane in 70^: 50^ oxygen), 
lasting less than 30 minutes, polyethylene catheters 
were introduced into the femoral artery and vein of each 
hindlimb* The incision sites were then liberally cowered 
with a cream containing a local anaesthetic (Anethaine) 
and closed with sutures* These areas were protected by 
pads impregnated with the same anaesthetic cream, ^^ nd an 
elasticated bandage,, before the application of a loose- 
fitting plaster cast around the lower abdomen to restrain 
the animal. Anaesthesia was discontinued * The
rats were allowed to recover for at least two hours before 
further manipulations were performed* During this time, 
core body temperature was measured by a rectal thermometer 
and maintained using heat lamps* Prior to commencing the 
experimental procedure, appropriate responses were elicited 
to slight auditory and sensory stimuli*
All rats, whether anaesthetised or conscious, had
measurements made of blood pressure and heart rate, (Gould) 
the partial pressures of oxygen and carbon dioxide and the 
pH of arterial blood (Corning) and the plasma glucose 
concentration (Beckman),
2*8. The measurement of local cerebral glucose utilisation. 
The measurement was initiated by the d elivery of a bolus 
intravenous injection of - 2 deoxyglucose (50 uCi
dissolved in 0.7 ml of saline.) During the subsequent 
45 minutes, 14 timed samples of arterial blood (approx­
imately 70 ul in volume) were obtained according to a 
pre-determined time schedule. These samples were immediately 
centrifuged* Twenty microlitres of plasma was withdrawn 
for the determination of concentrations, and a further
10 ul was used to measure the glucose concentration by 
means of a semi-automated glucose oxidase assay 
(Beckman U.S.A.) Forty-five minutes after the administration 
of the isotope, the rat was killed by decapitation*
Following this, the brain was carefully removed in under 
2.5 minutes and frozen in isopentane, cooled by a dry 
ice/acetone jacket to -45°G* The frozen brain was 
embedded in Tissue-Tek II (R.A. Lamb, London, U.K.) and 
coronal sections (20 microns thick) prepared in a cryostat 
maintained at -22^0. The entire length of the brain from 
the medulla oblongata to the prefrontal cortex was sampled, 
three sections being taken for every 260 microns of brain.
The sections were mounted on coverslips and rapidly dried 
on a hotplate. These coverslips were fixed to a pre-cut 
piece of cardboard which enabled them to maintain
maintain good contact when they were laid, along with 
pre-caliorated plastic standards (44 - 14-75 nCi/g,
against x-ray film (Kodak SB-5) in a light-tight x-ray 
cassette* After seven days the x-ray plates were 
developed by normal photographic procedures *
Sections immediate adjacent to those used for auto­
radiography were fixed in formalin and stained with 
cresyl violet for the identification of anatomical regions 
and nuclei in the autoradiographs with reference, of 
necessary, to the atlases of Konig and Klippel (1967) 
and Zeman and Innes (1963)* Using a computerised 
densitometer system (Gamma Scientific, U.S.A*), the mean 
of 12 optical density measurements per brain region wa.s 
calculated* This figure, when compared to the optical 
densities produced by the '^^ G standards, (lOOu ) gave the value 
of the tissue "^^ G concentrations* By using the
operational equation devised by Sokoloff et al, 1977, 
the concentration of ^^G in each brain region, the history 
of ^^ G^ and glucose levels in the arterial plasma during the 
experimental period and the appropriate rate constants for 
the rat, the rate of glucose utilisation in each brain
region was calculated*
2 * 9 Experimental Protocols for Drug Administration 
2 * 9 01 The effects of serotonin following clorgyline 
on local cerebral glucose utilisation.
The experiment commenced when 50 pg/kg/min of clorgyline 
at a rate of 100 pl/min, or the same volume of saline, was 
infused into the carotid catheter* After 15 minutes this
was replaced by either an infusion of serotonin at a 
concentration of 50 ng/kg/min and a rate of 100 ul/min, 
or the same volume of saline, and was continued for the 
duration of the measurement of local cerebral glucose 
utilisation, in these anaesthetised rats.
2*9.2. The effects of putative serotonin agonists on 
local cerebral glucose utilisation. 
quipazine maleate (2-(1-piperaainyl) quinoline maleate: 
courtesy of Miles Laboratories)was administered in doses 
of 1, 3 or 10 mg/kg, intravenously* Conscious rats were 
intravenously injected with lysergic acid diethylamide 
(L.S.L. : courtesy of Sandoz Laboratories)in doses of 5 ?
15, 50 or 150 ug/kg, 5-Methoxy N,N dimethyltryptamine 
(5MeO Sigma)wa,s administered in doses of 0*2, 0,75
or 2 mg/kg, intravenously * 6-Chloro-2 1-piperazinyl - 
pyrazine (O.P.P. courtesy of Merck, Sharpe and Lohme) was 
administered intravenously in doses of 0.8, 2*5 or 8 mg/kg* 
The drugs were all administered as a bolus in Iml/kg of 
saline 10 minutes before the infusion of 2 - deoxy­
glucose. (fig* 6) to the conscious rat preparation.
2*9*3 The effects of putative serotonin antagonists on 
local cerebral glucose u t i l i s a t i o n *
Methysergide bimaleate (Courtesy of Sandoz) was given in 
doses of 5 and 15 mg/kg intravenously* Metergoline 
(Parmitalia) was given intravenously in doses of 0*3 and 
3 mg/kg 0 cyproheptadine (Merck, Sharpe and Lohme) was 
administered in doses of 0*1 and 1*0 mg/kg intravenously*
All these drugs \æve administered in 1 m /kg of physiological 





































































2,9.4. The measurement of cardiovascular parameters.
The measurements of heart rate and mean arterial pressure 
quoted in this thesis were made at the end of the two hour 
recovery period, immediately prior to drug administration 
(controls), and immediately before the bolus administration 
of - 2 deoxyglucoseo
2.10. Statistical Analysis
Data are presented as mean + standard error of the mean, 
unless otherwise specifiedo Statistical differences in 
measured variables were analysed using the t-test by 
paired comparison when comparing regions bilaterally in 
the same animals, and by analysis of variance with the 
Scheffe test for multiple group analysis. The numbers of 
rats in each group are given under the appropriate headings 
in each table.
III. TH.I ACTIONS 0? SDROTOHIII ON LOCAL CERSBHAL 
CrLUGOSa UTILISATION FOLLOWING MÜNOAMIITS 
OXIDASE INHIBITION.
3.1. General Hesuits.
The administration of serotonin into the internal carotid 
artery, (50 ng/kg/min) had no significant effect on local 
cerebral glucose utilisation as compared to saline controls. 
Similarly, clorgyline, the monoamine oxidase A inhibitor, 
(Johnston, 1968) produced onlyminimal effects on glucose 
use by itself. (Table 1)
hollowing a combination of serotonin and clorgyline, the 
majority of structures measured showed little change in the 
rate of glucose use. Only six out of the 34 brain areas 
measured, displayed significant changes following clorgyline 
and serotonin, with decreases in glucose utilisation of 
between l6^ o and 337°o All but one of these regions were 
cnrtical, the exception being the caudate nucleus* All 
of these areas would normally be supplied by blood from 
the internal carotid artery* However, not all such areas 
showed changes in the rate at which they used glucose, e.g. 
the hippocampus and cingulate cortex (Table 1). None of the 
brain regions perfused by blood from the vertebro-basilar 
arteries shov/ed significant changes in local cerebral 
glucose utilisation* None of these manipulations affected 
the blood pressure or heart rate of these animals. (Table 2 )
3 o 2. Comments on Results
The results show that the intracarotid administration of
serotonin is incapable, by itself, of affecting local 
cerebral glucose utilisation* This is obviously due 
not only to the presence of a physical blood-brain 
barrier, but is also due to the presence,in the endothelia 
of cerebral vessels,of the major catabolic enzyme for 
serotonin, monoamine oxidase, (Hardebo and Owraan, 1980), 
When this enzyme is inhibited by the specific monoamine 
oxidase A inhibitor, clorgyline (Johnston, 1968) given 
into the carotid at a cose of 50 ng/kg/min, serotonin is 
able to cause a number of discrete decreases in local 
cerebral glucose utilisation* However, there are a number 
of disadvantages with the protocol. Firstly, the effects 
of serotonin fol lowing clorgyline could be seen 
only within areas of the brain supplied by blood from 
the carotid artery* This did not allow investigation of 
such important serotoninergic areas such as the raphe 
nuclei* Hecondly, the effects were small and did not occur 
in all of the areas making up carotid territory* Thirdly, 
and perhaps of most, importance, the rats are anaesthetised 
As can be seen from Table 3, halothane anaesthesia, 
administered as described previously for this preparation, 
significantly decreased glucose utilisation in a diverse 
range of anatomically defined areas of the rat forebrain 
as compared to conscious controls* Prom this data it is 
clear that serotonin is producing its effects against a 
background of depressed cerebral fu.nction*
It was necessary to find a new animal model* One of the 
major advantages of the deoxyglucose quantitative
autoradiographic technique is that it can be used with 
fully conscious rats. Pharmacological manipulation of 
the central serotonin system was therefore continued 
using the intravenous administration of putative serotonin 
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Anterior Cingulate Cortex 
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G r o u p _____
102 ± 2 73 + 3 * * *
139 + 5 80 4- 2 X * *
95 + 2 57 ± 2 X X X
92 4 56 ± 2 X X X
71 2 36 + 4 X X X
104 ± 1 81 + 6 X X
93 ± 6 49 + 3 X X X
94 ± 2 90 + 5
93 ± 4 68 + 4 X X
119 + 3 63 + 3 X X X
91 ± 4 72 + 1 X X
80 ± 4 59 + 4 X X
104 ± 4 101 + 8
108 + 4 86 ± 2 X X
92 + 2 85 + 6
77 ± 4 59 ± 5 X
98
± 4 58 ± 1 X X X
70 + 2 63 + 5
115 ± 3 73 ± 1 X X X
83 ± 4 66 + 2 X
53 + 2 38 ± 3 X X
82 ± 3 79 + 2
65. + 2 64 ± 2
62 + 3 48 ± 3 X
57 ± 3 36 + 2 X X X
48 + 2 33 + 1 X X
71 + 3 41 3 X X X
73 ± 4 66 4
60
± 3 38 ± 4 X X
59 + 3 46 2 X
93 5 62 ± 6 X X
88 ± 4 73 i 5
52 ± 2 44 + 6
81 + 2 70 + 5
60 ± 2 39 ± 4 X X
77 + 4 57 ± 3 X
70 ± 2 46 3 X X X
102 ± 2 67 ± 4 X X X
90 + 6 60 + 4 X X
49 + 3 34 3 X
66 + 4 38 5 X X
84 ± 2 57 ± 7 X X
83, ± 3 69 + 5 X
81 ± 3 61 ± 4 X X








136 + 7 






X*86 + 5 
69 + 9 *** 




Genu of the Corpus Callosum
Internal Capsule
n
33 + 4 22 + 1
33 + 4 29 + 2
28 2 22 + 1 *
34 + 2 22 + P  X X
6 5
Data are given as mean + standard error of the mean*
* : p<0o05 ** : p<0o01 *** : p<0.001
Statistical analysis by t-test by unpaired comparison.
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IV* THE EFFECTS OF INDOLEAMINB-GONTAINING SEROTONIN 
AGONISTS ON LOCAL CEREBRAL GLUCOSE UTILISATION.
4 o 1. Behavioural effects
In these experiments behaviour was observed but not 
quantified. Despite the fact that the hindlimbs were 
not allowed free movement, the upper body was able to 
respond to drug treatment as previously described.
(Gessner and Page, 1962; Grahame-Smith, 1971 )o Saline 
control animals showed little obvious sustained behaviour 
other than licking and general cleaning* With low doses 
of both lysergic acid diethylamide (L.S.D.) and 5-methoxy 
N,N-dimethyltryptamine (5MeO) there was a short, but vivid 
increase in the general activity of the rat, particularly 
sniffing* Increasing the dose produced a more sustained 
and complex behavioural pattern* This included side-to- 
side head movements and forepaw padding which, with time, 
gave way to forepaw rigidity and splayed toes.
4o 2* Cardiovascular effects
L.S.D. affected blood pressure only at the highest dose 
(150 ug/kg), producing a 7 + 3^ increase (mean + SEM; 
p<0*05)o The heart rate was significantly reduced by 
L.S.D. at doses of 15, 50 and 150 ug/kg; with a maximal 
change of 16 + 4^ (p<0*05) ocurring at 50 ug/kg * (table 4) 
5MeO produced similar changes in blood pressure and heart 
rate at doses of 750 and 2,000 ug/kg, blood pressure being 
increased by 23 + 3/° (p<'0*05) at a dose of 2,000 ug/kg 
and heart rate being reduced by, 11+ 4^ (p<0*05) by the
same dose (ïeble 6).
4.3 o Local Cerebral Glucose Utilisation.
4.3* 1, Cortical Areas
As can be sa en from the results (Tables 5 and 7), LSD 
and 5MeO produce parallel decreases in glucose utilis­
ation in cortical areas* The most sensitive areas appear 
to be ’limbic cartex' (Robertson and Katz, 1981), In 
narticular,.nyriform cortex, posterior cingulate cortex 
and nrefrontal cortex are markedly affected, even at low 
doses of these compounds* (see Fig. 7) By comparison, 
the glucose use of cortical areas subserving sensory 
function, such as parietal and sensory-motor cortex, a r e  
significantly affected only at the highest dose levels 
nf LSD and TMeO* (Tcables 5 and 7)
 ^=3,2, Diencerhalic 1reas
Both of these putative serotonin aronists r.roduced 
significant decreases in th'-^ lat-'-^ ral nucleus of the 
thalamus and the medial and ventral portions of the 
anterior thalamus, (Fig. 8) while having lesser effects 
on the glucose use of t^e mcdiodorsal and ventrolateral 
nuclei, whu.ch were affected only at the highest doses*
Tn tbe hypothalamus, the medial nuclei and rerivcntricular 
nucleus show little chanre in the rate of aiucose usare, 
However, LSD 'ncduc^s birhly significant decreases in 
glucose phosrhoryl etion in the med-ian forebrain handle ; 
BrieO also induces decreased ra*tes of glucose use, but to 
■ a lesser pxtent* The habenular comnlex of the
L o c a l  C e r e b r a l  G l u c o s e  U t i l i s a t i o n
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epithalaraus had a decreased rate of glucose use following 
LSD and 5MeO administration, hmt again this effect v/a.s 
only significant at the highest dose, (Tables 5 and 7)
4- o 3 . 3 3 Limhic Areas
The nucleus accumbens, anterior amygdaloid area and 
dentate gyrus have significantly decreased rates of 
glucose use even follov/inglow■ doses of L.S.D. ('15 ug/kg) 
suggesting a greater sensitivity of these areas to this 
drug, 5MeO, however, had no significant effect on the 
glucose utilisation of limbic structures at the lowest 
dose (200 ug/kg), but all the structures were markedly 
decreased a.t the next highest dose (750 ug/kg) o 
(Tables 5 and 7)
4.3 o 4. Extrapyramidal Areas .
Both LSD and 5Me0 decrease glucose utilisation in the 
major extrapyramidal regions of the rat brain. (Dig.9)
In the four areas of the caudate nucleus measured, parallel 
changes occurred. With each drug the caudal portion of the 
caudate nucleus was most affected, while the decrease in 
glucose phosphorylation in the body of the caudate nucleus 
was less marked. (Tables 5 and 7) The effects of these 
two compounds on the substantia nigra was to produce 
parallel decreases in the rate of glucose use in the 
pars compacta and pars reticulata of this structurée 
LSD produces a rather uniform decrease in glucose use in 
the a] obus pallidus with all, four doses used. This is in 
contrast to 5MeO which causes a y^recipitate fall in glucose 
phosphorylation in this structure between doses of 200 a.nd 
750 ug/kg^
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4,3 . 5 o Primary Visual and Primary Auditory Areas 
There are differences in the way in which these putative 
serotonin agonists act on primary visual and auditory 
related cerebral regionso With both these drugs, the 
areas making up the visual pathway show significant 
decreases in glucose phosphorylation, particularly in 
the lateral geniculate body and the superior colliculus.
The primary auditory structures, although they show a. 
significant decrease in the rate of glucose use with the 
highest dose of LSD (150 ug/kg), display no significant 
changes in glucose utilisation following 5MeOo 
1 .3.60 Hindbrain Areas and Myelinated Fiber Tracts 
LSD and 5MeO affect glucose .utilisation in the cerebellar 
areas to a lesser extent than in forebrain areas* This 
rattern is maintained in other hindbrain areas (Tables 5 
and 7 and previous section). The dorsal and median 
raphe nuclei are an exception to this in that they display 
significant decreases in glucose usage following LSD and 
5MeO treatment.
The white matter fiber tracts are perhaps the least affected 
cerebral areas to be measured (Tables 5  and 7 ) o
Comments on Results :
The hyperactivity syndrome induced by Lysergic a c i d  
diethylamide (LoS.D*) and 5 ilethoxy -iI,N -dimethyltryptamine 
(5MeO) was qualitatively similar to that observed by previous 
investigators (Gessner and Page, 1962; Grahame-Smith, 1971a) 
This syndrome was in turn similar to that produced by
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L"tryptopha.n administered after monoamine oxidase 
inhibition (Grahame-Smith, 1971b)o Neither L.S.D. 
nor IMrO may be considered to be acting exclusively 
on 9HT receptors. It should be noted that the central 
dopaminergic system has been implicated in the actions 
of LSD and 5MeO. (Green and Grahame-Smith, 1974; fieri 
et al, 1974.) LSD also binds to dopamine receptors 
(Whittaker, 1979). This does not necessarily imrly a 
direct cerebral action via, dopamine receptors since 
dopamine agonists may inhibit h-hydroxtryptophan-induced 
behaviour but do not induce it o (Volkman et al, 1978;
Weiner et al, 1979). Thus, it may be stated with some 
confidence that the behavioural pattern produced by these 
indoleamine-containing compounds involves the central 
serotonin system^ (See Sloviter, 1978, for review).
The peripheral 
effects of 5HT and putative serotonin agonists on blood 
pressure are highly complex. LSD and 5MeO do produce marked 
cardiovascular effects but mainly at the hi.ghest dose levels 
used. It seems likely that the pressor effect and 
bradycardia observed may well be derived from a combination 
of both the peripheral and central actions of these compounds 
(See Goodman and Gilman, 1979; Kuhn et al, 1980 for reviews)
Local cerebral glucose utilisation was measured in sixty 
anatomically discrete areas of the brain. None of the areas 
measured showed increases in glucose utilisation. The 
majority of brain regions reacted to the administration of 
LSD and 5MeO with dose-dependent decreases in glucose use, 
(Tables 5 and 7) In fact, very few areas did not show a
decrease in function at the highest doses of these drugs. 
Where a significant response was obtained, LoS.D. produced 
changes in the rate of glucose use at much lower doses than 
5MeO. Overall, 15ug/kg ioV, of L.S.D. produced a similar 
decrease in glucose use as 750ug/kg of 5MeO; a difference 
in potency of about 50 times.
The majority of electrophysiological data suggests that 
the stimulation of raphe nuclei produces an inhibition in 
the cell-firing rate of post-synaptic (non-serotonergic) 
cells. (Bloom et al, 1972; Dray et al, 1978; Olpe and 
Koella, 1977; Segal, 1975; Wang and Aghajanian, 1977). 
furthermore, the iontophoretic ejection of 5HT mimics this 
effect, (Bloom et al, 1972; Haigler and Aghajanian, 1974-; 
Wang and Aghajanian, 1977)° '
Much attention has been paid by electrophysiologists to 
the actions of L.S.D., 5MeO and other 5HT-like compounds on 
the firing rate of the 5HT-containing cells in the hindbrain 
raphe nuclei. (Aghajanian and V n der Maelen, 1982; Haigler 
1981, for review and Roganski and Aghajanian, 1981), These 
investigators have found that L.S.D. and 5MeO decrease the 
spontaneous firing activity of raphe neurons, for this 
reason it has been suggested that much of their central 
effect is due to a preferential action of L.S.D. and 5MeO on 
5HT receptors situated on the serotoninergic cell-bodies, 
(Aghajanian et al, 1972; de Montagny and Aghajanian, 1977). 
In view of this data, it might seem that there is a good 
correlation with the present findings using deoxyglucose.
The electrophysiological data, although produced by a method 
in many ways very different from the ^^G-2 deoxyglucose 
technique, is at least comparable measure of functional
activity. Therefore, it can be concluded that there is 
at least a qualitative compatability, This view is 
strengthened by the evidence that there is a close 
correlation between the level of deoxyglucose phosphory­
lation and the activity of Na**~ - ATPase in nervous
tissue (Mata et al, 1980) and that in consequence changes 
in glucose utilisation reflect changes in nervous activity.
One problem arises, however, from the work of Haigler and 
Aghajanian, 1974, who found that the intravenous administ­
ration of L.S.D. at a dose of 20 ug/kg, produced an 
acceleration of the firing rate of cells which reacted 
with a decrease in activity to 5HT administration. It is 
difficult, given the lack of increased glucose use in this 
study following similar doses of L.S.D., to reconcile these 
qualitatively opposing data at the present state of knowledge,
In summary, L.S.D. and 5MeO produced significant decreases in 
local cerebral glucose utilisation. Particularly sensitive 
areas were:- Cortex - posterior cingulate cortex.
- pyriform cortex.
- prefrontal cortex.
Thalamus - medial and ventral anterior nuclei.
- lateral nucleus.
Limbic System - n. accumbens.
- anterior amygdaloid area
- dentate gyrus.
Extrapyramidal System - caudate nucleus
- substantia nigra 
Visual System - lateral geniculate body
- superior colliculus 














y  CD Çû ÇD




* ü VJ] VJ] -i^ 0 0
m 00 vD ro 0 M 0




0 m 1 + 1 + 1 + 14- d P H
0 P 0 d 0







en d c+ cd
c+ (D CD H
Çû 03 ïi>
c f CD /— y j
H - d CJ"
td03 c+ c+
c+ CD VJ] VJl -F=. 03 >
H- Qj ■F^ 0 0 M \ H3




M 03 C7V 1 + 1 + i + d d
M M ty
M 5 H 0 Vj ] rv3 03
0" P M H* H H M 0
d (\0 VJ] no H Vj ] 0
>
VJl VJl ov -J d bd
p
en 1 + 1 +
c+ H
d 1 + 14- 1 + d 0
0 pj 0 0











1-+) d " M H M H M ' -- N
H) CD VJ] Vj ] rvj H VJ] M




CD en 1 + 1 + ! + 1 + P X I
P t y -— '
d Vj ] VJ] Vj ] -R. ro
hd h j > h i ’x ) t?d 03 h j O
4 o d d d CD p CD
CD 03 cd- o d d d d d
H j c+ CD d H- o Ui H- CD
d CD d d - d O CD ch
D d H - p o îh d d d
P H - O H d H- ' d P p
c d O d 3 d 1 H M
P d a p g
M O o o h-J o O 0 3
o H ' d o d o d
O H - d c+ d O O d d
O d % CD d - o d d d
d % d W CD d CD o
cf d M d O X d
CD H Ü3 CD O d
P d- X d d













ro vo vo v o vo -d vo vO cn
VXI vo d ] 00 -F^ P
1 +
M
1 + 1+ 1+ 1 + \ + 1 + 1 + H-
Vj] VJ] - h Vj] VJ] VJ] CD
vO 0 0 - d vo -0 cn vD vo
-f^ VO ro 0 0 cn -F^ ro
1 + 1 + 1 + 1 + 1 + 1 + 1 + 1 +
rv) Vj ] VJl Vj ] ro -F:^ VjJ - d
* * H<
VD - d 00 VO - 0 cn VD CO
vo Vj ] H rv i c n ro O ro
1 + 1 + 1 + 1 + 1 + 1 + 1 + 1 +
CT\ - h (V) ■ d V j ] -F^ v n - p
* * +
vC - 0 00 V D cn v n vo GO
V j ] O d v n cn 00 ro ro
1 + 1 + 1 + 1 + 1 + 1 + 1 + 1 +
VJ] Vj ] VJl d VJO ro - d VJ]









































c n v n c n v n -F^ c n c n
VJl -F^ - O 0 0 CjJ d c n
1 + ! + 1 + 1 + 1 + 1 + 1 + 1 +
VJl - h -F^ ro ro -F^ v n




hd S bl tS) CD d d d d d d P! b:] ü
CD CD O P P d p- P' P" P P P H-
h P d P P o P P P P P (P cc P
H- H* o P d d d d d d d p p P
< P c+ P p P P P P P P P OCD îb d d P P 3 3 3 3 3 j^ P Pb P P d p P P P P P d d P
d hrj d O P ro ro m ro ro p p pr
h O P CD 3 d 1 P
H- y 3 P H* p —^-X ,--N X—s 1 -^X y-'N d
O CD P d O P d > >> <1 3 d H‘
P d 03 P P p P P p  ^ P p O
d y d H- d d d p 3 Pi d
P p P P P P p d P H* P CD
H H- 3 Q P P P P P pi P P d
P a> d ro P H* H- O H- d  P P
d P P d O O 1—' O ' 1—1 P
P bd H- P P P P pi O
O p P 03 p 1 1 d o d
d p d p 3 <! P p P
CD p o p p P ro P
,P 1—1 d Cb P P P P
03 CD p H* d d d ro
P P P






d 1-' d -«—- \_X d
-P' en vjn d d vD o d d 00 VD -0 o CD
VD en d d VD VD ro VJl vn ■d -d ro d P
1 + 1 + 1 + 1 + t + 1 + 1 + 14- 14- 14- 14- 14- 14- H-
VJl ro VM VJl ro 4^ ro VjI VjJ ro ro -d  vjj P
d d
V n v n - f i . - O d ! O - d v D v D - d ) 0 3 d ! O  
- d o O o r o v n d o o v M c n - d v O d o
1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ |-f 1+ 1 +
rovjirovjivjirovjidvM-h 
* :f: * *
4i>vji-dorcnvOd]vovDcncx)vjivû
v o c n u i O v D d v D - f ^ d Œ ) ! \ J c n d
1+ 1+ 1+ 1+ 1+ 1+ i+  1+ 1+ 1+ 1+ 1+ 1 +



































en d  00
00 VX VJ] -o d d' d
CD
VJl




!+ 1+ 1+ 1+ 1+ !+ 1+ 1+ 1+ 1+ 1+ 1+ 1 +
v j i d r o v J i v j J  r o v n v n v j i - d v j i v j i q ^
vn
O
v n v n - h v n v j ie n v n c n v n v n c n v n d  
d o d v j i v n ( V ) v D d v D ( X  en d  vn





c > > m C/2 bf m tP
n> g B p P p H- H-
td eh o P x i B
c+ CD % M ct- c+ c4- X i ey
H y pj P p p p o H-
fU H- p P M H c+ o o
M O M M p p
l-j p B U2
1-3 > 5d P Q bd c+
CD > ,— ■. O O O P y
% B O M 1— 1 y P P
B p g P p P o
Q oq p. B sb p p /-N c+
!d H* p" Ui m B P
c+ P P p o y
P H M y /— - --\ H p
H o Ui B p P p
H- y p P O
> pj P P cf P
4 O H- P M
CD > H P y 0)
P y P H p y





CT\ CD -f^ OD 4^ un ~d 00
UD 4^ O en en un en co














un en 4^ en un un en -4)
en O CD 4^ M un
1 + 1 + 1 + 1 + 1 + 1 + 1 + 1+
un fU UJ M M un -F^ 4=^








U en un en un un un -u
ru (U uo (U eo O 4^ o
+ 1 + 1 + 1 + 1 + 1+ ! + ! +





un. en 4^ en un 4^ 4^ en
O un M o en vo vo en
1 + 1 + 1 + 1 + 1 + 1 + 1 + 1 +
pj ru un un ro un pj H
* * % * *
un
lo
.p. un un u un un u un
un u vjd un vo lu H kD H
un
+ 1 + 1 + 1 + 1+ 1 + 1 + t + O
un un ru .p. lU un un un
* * 4c * 4c
3 0
< M W en œ Q a bdp P p P P M P X >ra H] CP b o P c4- bdc+ P üi p u Çh yH- y c+ c+ P P p bdH- P P p p y- p
P o O y y p unM y M c4- c+ hd 1 1 ! 1 y
P P H- H- P b! p oy o P P P M P B oM W M o cp pu o H-H- tp H" P (D O o H ly
P <1 H- H’ pu P y pu y (D P WO p Cbi vq P pj c+ 0) P H tH y y P P y o mP P p H o H 02
P B p ! c+
0} p (H- y
bd bd pu CD P
P P H* y oy y P p y-
0) p M M Pyy o CDp o Oî






O -u -UI en 00 un 00 00 00 uo GQ ;-d
VO un en o H -P- fU P* u>n p P yM M
! + 1 + 1 + 1 + 1 + 1+ 14- 14- 14- 14- H- O





CO un -UI -p' en -P en en -u 00 h3
<o UD un UD M un 00 00 M H
un
1 + 1+ 1 + 1 + 1 + 1 + 14- 14- 14- 14-
en un -P- un M fU M fU
* % * 4c 1bd
bd
vo en en -P- un -P en en -Uî -U] -^N
lu -f^ lU eo un un uo O 00
H
1 + 1 + 1 + 1+ 1 + 1 + 14- 1-b 14- |4- un bp
vn un 4^ -p> un Ujn un -p un P* * *
UD -U en -p - un •P^ en en en ~U
un pj un PJ 00 -UI -u en uo en jun
lo
1 + 1 + 1 + 1 + 1 + 1 + 14- 14- 14- 14-
U1 un un lu l U un l U un P P
* 4= 4c
en un -p^ un - p un un un en Mco un -p- M M - u un u d 00 t - * un
O
! + 1 + 1 + 1 + 1 + 1 + 14- 14- 14- 14-
-p. -p- lU un un lU un UP un
* * * * 4= * 4c
n O o [3, Ü 'P o o O o bd y
y (D D •C T) O O p p P p H- b>
y- y y (D CL y y y y y y y bd
(D P ■y M H- co co p p p p y y
y P H- p p o" en en en en bd
y o Ui y y M '-s p p p 0 y
p H) 33 y ]— 1 y y p un
h-j o c+ 53 * CD M y y y H-
O P (D p P y- P P P P y oo o M O j bd bd H- ■3 B B B
p y M y y o
bd X O CD (D p < y
co P Ui H- M y p p G td
P co P en S p H- y o B
M B (D P P y y B y y
CD o y O O p H* p S3
p M M Hj Ui H* bd
M t-3 (D CD O 3 y
M y P P y P p
O p Ui Ui B y y
U) o '0 y p
p y- y p
B co H- y
lU) un U3 Ud 03 UI uo 03 VJl en 3
U3 y 1^ CTi un y un 03 Ud y P o
1 + 14-
y y
14- 14- 14- 14- 14- 14- 14- If H- o
y ru> :V) un UJ y fU -y y Uî yp >
U>l u un 00 y un un y y y
y y 03 y un un ro ud 03 03
14- 14- 14- 14- 14- 14- 14- 14- 14- 14-
un y UJ y y
*
un y y U>3 ui
un y un y y un un y y yy y y ro un O y y Ud y
l-b 14- 14- 14- 14- 14- 14- 1-H i-b 14-






u fO r o 0 3 0 3 y wn y y
u n 03 y y O Ou 03 u n
+ 14- 14- 14- 1-b 14- 14- | f 14- 14-




un un un 03 03 y Us] y y un
y 3 y y y y O 03 y [3J
14- 14- 1 + 14- 14- \ + 1 + 14- 14- 14-






























































y O co y y > y y
p o p p P p P p >
o bd y Hj y y H- bd
B y P p P H- H- B y
p y P P P o y p bd
p p H- P H- P o p
p O y O y P y un
p P P y
< y y > o
H- y O p O p o p O
P p y B O P o y y
P o H- p y H- p H- y
P y <! H* y O c+ y y
1—' p p Ui P CD o
P O o y X P







y  B p 
o  o y  
<  y  P
>  p 
\ p  
p  y  p
P O P
y  o  
gq oq 
c o \ y  









P O  
p un m 
bd 0 y  
p P
o P
y  co y  
y  p 
y  P P 



























y  y  y  
p p 
o Ui
y  H- B







y y y y y y co
ce 00 CO 00 UD -y -y y 03 y un P
o -F^ 03 un UD o y f3J GO un UD y
+ 1 +
H-
1 + 1 + 1 + l - f 1 + ! + 1 + 1 + 1 + P
P
U>l f3J 130 y un un y un un un un
y y y y y
03 y 03 -p uo un U) 03 o un00 y 03 00 y y y uo 130 03 03
1 + I f 1 + 1 + 1 + 1+ 1 + 1 + I f I f I f
un 130 UI un un y y un y un y









03 o y uo 00 uo 03 03 o 03 un
03 I f I f I f I f I f I f I f j f I f I f I f
un y un un y 03 03 y un un un4c 4c
y y y y03 y 03 y 00 un un uD 03 uO [30un un un y y un un uo y UO un
i f I f i f I f I f 1 + I f I f I f I f I f
y [30 un un un 03 un un (03 y un
* 4c 4c 4c 4=
y
'UI 03 un un 03 y y y 00 uo
uo M ro y un 03 y o 03 ro
I f I f I f I f I f I f I f I f I f I f I f
UJ un y un un VJI un y y un y





















o y fU) H- p 03
o un - o P Cfq
o o o p \
oq
% ü un - y - y y o
p 00 o y ro o Pd
• • y ce 00 un o P p
P
14- ' 1 +
c4 p
' p 03 14 l 4 P p
A p y y O y










y p un un y y y
H- y 03 y y Ui
Ui y f3J y UD hd \
y P p B
H- Ui 03 14- 1 + 14 14 p H*
o y y FV P















y y y y y o  ■
> ro y y un o bd




y P 03 14- 14 14 P O
> o o pj









y 3 y y y y
y p un ro un ^— -,














y y > y y y en y o y
p o P p p p p p
p en y o p y P p P bd
y y p p H- y m H- p y
p p P y y o o P y y
o P H- p o p P y p
P H- o y p y '<! P P
y O p B H- y y
P P o P 1
y o o o P o o
O H- p o y S o o
o H- P y p o p P
o P Oq p y o y y y
p oq P X p o o p p
y P y X p P X X
p 1—1 p y
X p y p o U l
y p X o y
p p P
o y P
a o p o






ro uo UD uo uo y 'UO uo
-y U) y y y y 00 y
4 14 14 14 14 14 14 |4
y 4^ un y y -y y un
00 y y uo y 03 00 y
un y y y o ro 03 03
14 14 14 14 14 14 14 14
y y un y ro un un un
* * 4c 4c
uo y y 00 03 un 00 y
o un y O y 00 un y
14 14 14 14 14 14 14 14
un ro ro ro un y y un












00 un 03 00 un un uo y ro
un y uo un 03 O y y O
O


























































y 3 y es en ep y y y y y y y y yp p y o P P y y y y p p H- b>
p y PJ p y o P p P p P y y P bd
H- p- o p c+ y y y y y y p p P y
< p c+- y p P P p p p p P O y
P P y M p P B B B B 3 P P P
P p P y en P P P P P y I—J 3P yy y y P P en en en en co P yP o P P B W p o
H- p 3 P H' p I 1 1 1 1 %— \ .— s y oO p P y O P S y p-P y p P P y >* > < S p p o yy p H- P P p p y y y
p -— P P c+ c+ c+ P Oj H- p en .P H- 3 O P p p p C+ H- p P y
P P y M P p p P O y P Py p P H- H- O y s_, y P
o bd H- P y O O y o '— ^ o
P p en B P P P y
P y y p <î y en P
y • y P p P p










y y y yun y un y y VD o y y OC UD y OO y ro y vO UD ro y y y y y y
1+ 1 + 14 14 14 14 14 14 14 14 14 14 14
y ro U4 •y no y ro y y ro !—! y y
y y03 y y y y 00 00 o o y en y uo130 o cc o ro 00 o y y y y y y
1 + 14- 14 14 14 14 14 14 14 14 14 14 14
ro y ro y y y y y y y y y y4c 4c 4c
y y un 00 03 00 y 00 00 y y y 00un y o uD y y y ru) 00 UD y uD 00
1 + 14 14 1 + 14 14 14 14 14 14 14 14 14
ro un y y y ro ro y y y y y y4c 4c 4c 4c 4c 4c 4c 4c 4c 4c
P y un y y 03 03 03 y y y y—0 un y o o y y 03 00 uD uo y o














un y y 







< > > en en w PI tP y
p P 3 P p p p p* H- >
p c+ O bd bd p ’■d B bd
y p oq y y y y bd y y
P p y p p P p o H- td
P H* P P y y y o o
y O y p p P -y
P P
> ?
rp B ce oy • y bd y
p > -^s o =<! P P o
oq B B o p p P
B y p p B y P o yp oq y B p p en ,-- -X y W
P y H- y y y 3 P •
y P P p H- p o p
P y y P p P y p











03 œ -y co -y un y 00 en y
uD -y y o y 03 un 03 p O
y X
1 + 4+ 14 14 |4 14 14 14 H- y
4- un un PO un un y un P 1
y y -y y -y un y y
00 03 o l\0 un un 03 y [30
O
4 14 14 14 14 14 14 14 O
un un un y ro un -y un
-y un un un un y un 03 Hy y un un y un y y 'Xun td
4 14 14 14 14 14 14 14 O
y y un ro un y un











y u n u n 0 3 y y y 0 3
y u n r o y y y y r o 3 0




u n u n ro un r o (30 [30 y
4c 4c '4 4c 4c 4c 4 4
y y X ce O o te y
p P p P y P X p*
p y y y o P c+ üdy p p y y p y
H- p tp y P p p tdy H- P P p y X
P O o P p yy P y y y p
p p H- p 'X p o
p O P p y P B oy p y o H- fei
îp H- H- y y yp < H* y p P üo p oq P P y •y P p p
p P ce
p y
p X-N p <: y y P
•p xi p p o o PO P p p y p o
p P y y p y
p p P p o Py o y P
p o '--V B p p
p o p y p
y B y p
H- pi H- p
O P P P






o y y 03 00 un 00 00 00 vD
vO un 03 O y -y ro y- un y
1 + 1 + 1 + 1 + 1 + 1 + 14 14 14 14
y- ■y un ro un un rv) y ro y
00 03 y '_n 03 un y 03 00 y
cc y o un 00 y (30 y y un
14 14 14 14 14 14 14 14 14 14
un (30 ro (30 y ro (30 ro y y
4 4 4 4 4 4
00 un un un un un un 03 03 03
03 o 03 00 y 00 03 y (30 00
4 14 14 14 14 14 14 14 14 14
y un (30 r\0 ro ro ro (30 (30 y













00 03 03 y 03 un 03 03 03 03
O y y y un 00 'jn 00 un UD
4 14 14 14 14 14 14 14 14 14
y un y (30 un un un un y
4 4 4 4 4 4 4 4
D O
t—1 O o 1 3 : 3 W p j o o O O b p y
p p o y p o o p p P P H - >
y P p p y P P P P P P P b d
p b d y M - p Ui p p P P y y
p P H - P P y y c f en P L d
P o 03 P P y —s p p p p Py> y p p y y y y p y
o y îb) W p y y y t—1 H -
y P p P P y p p P P o
O P" y y bd bd H- a B B oP p y P" O P ce
Td o d p P < o rp y yp o 03 H - y P" p y p p td
P o p y P: P H - P p B P ,y P 3 p P p p y B H * H - op bd p o o p H - Ui y
P y y y 03 ■P P
w y p p o 3 P' P
p P P p p P p
o p ca Ui B y P Ui
P o ro y P
y y y p
y p p. P
un 30 un vD no 03 \n vD 00 v_nun y y 03 un y un 03 no y
1 + i + 14 14 14 14 14 14 14 14
30 30 'OO un 30 un y y
un un Fc. y y un un CO y y03 o 30 03 y un 00 un un y
14 14 14 14 14 14 14 1 + 14 14




un un 03 30 y
■y un un y 03 y 'y y y V>J
un y y o y 03 03 03 'sJl y
14 14 14 14 14 14 14 14 14 14
y y '^OJ y un y y vn y y
4 4 4 4
y un un 03 03 y y 03 y un
jn y un y nû 00 03 00 un 00
d- 14 14 14 14 14 14 14 14 14
y — j y ■y! y y y y y un













ce y y y o ce y y S > y y
P p H- p o p p P P p p >
d y CO H- o X y y Ch y H- y
Q CD P 3 y p p p H* H- 3 y
P P P ?j y p P p P y d td
H- P y P (D H- P H- y o P
O i--" •<! p O y O t-i y y
P o p P P o y
O o y y p > o
O p p H- P i O p O P o d o
O P y 03 p y 3 o  . M- o y y ;
y H* p p o H- P y O p H- y
y O X p <î H- y p y y y
r-'- P y p P m H- p o >
O y p o O p X P
p co P P y y




>  p y
teîB p
o  o y
y  y P
>  Ul
\ E ü




c e \ y
o  3
P' H- p
















O Py  ce y
y  fu
y  çû p
o  y  y
CO co p

















y y Ul d y
p p P p o
p bd P P
X p p y co









y t--" y s—1 y y
00 00 œ vd nO y .n !—' 03 y y;
o 03 y nD y y OC un uD
14 14 14 1 + 14 14 14 14 i f 14 14
un ro y y y un y vjn 03 y
y y
y y 03 - ] 30 O o 00 '.J3 oo f'O
un 03 y y y y UD O UD y
|4 14 14 14 14 14 If 14 14 14 14
y un un un 03 y y 03 ■di 03
4 4 4 4
1—1 y i_j
03 y un 03 00 y ' D 03 uD y
un 30 UT. 03 y y y y 'JO y o
14 14 | 4 14 1 4 | 4 14 14 14 14 14
y
AO 30 y y y o 03 y un y un














ouD 'D y 3 y y 'Ul y y •jn us o
4 14 14 14 14 14 14 14 14 14 If
o
un y] y y y 00 un un un un
4 4 4 4 4 4 4
V. THE EFFECTS OF PIPERAZINE-GOMTAINING SEROTONIN 
AGONISTS ON LOCAL CEREBRAL HLUGQSE UTILISATION
5.1. Behavioural Effects
Saline control animals, two hours after the discontinuation 
of anaesthesia, displayed normal grooming behaviouro 
Quipazine and chloropiperazinylpyrazine (C.P.l.) produced 
an obvious increase in activity. Despite the qualitative 
nature of these observations it was clear that the lowest 
doses of these two compounds produced only an increase in 
sniffing and movement. At the highest doses, the rats 
displayed a pronounced behavioural pattern of response 
including head-weaving and padding of the forepawso These 
effects normally lasted for thirty minutes, i.e. until the 
twentieth minute of the measurement of glucose utilisationo
5.2, Cardiovascular Effects
Quipazine and G.P.B. both produced vivid effects on heart 
rate and mean arterial blood pressure. Quipazine produced 
significant decreases in heart rate (12^ - 34^) and 
concommitant increases in mean arterial blood pressure 
(18^ - 41^). In a similar fashion, O.P.P. reduced heart 
rate significantly at all doses used, by between 11^ , and 20% 
and increased mean arterial pressure by between 21% and 36% 
(Tables 8 and lO).
5 o 3 o Local Cerebral Glucose Utilisation
5o3.1. Cortical Areas
Both quipazine and chloropiperazinylpyrazine (G.P.P.) 
produce dose-dependant decreases in glucose utilisationo 
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Figure lOp Log dose-response curves to quipazine and 
chloropiperazinylpyrazine (C.P.P.)-cortical areas. Results 
are given as percent change from control valuesQuipazine 
was administered in doses of 1, 5 and lOmg/kg and C.P.P.in 
doses of 0.8, 2.5 and 8,0 mg/kg. *p:<0o05. Statistical 
analysis by ANOVA and Scheffe with respect to saline controls
(8 mg/kg and 10 mg/kg respectively) produces significant 
decreases in glucose use in all the cortical areas 
measured; with the exception of a muted response of the 
frontal cortex to quipazine administration^ Especially 
cingulate and entorhinal cortices, which have significantly 
decreased levels of glucose use at 0.8 mg/kg of G.P.P. and 
1 mg/kg quipazine are sensitive to C.P.P. and quipazine 
administration. (Pig. 10)
5.3.2. Diencephalic Areas
There is a distinct dichotomy in the actions of C.P.P. 
and quipazine on glucose utilisation in diencephalic areas. 
Quipazine produced increases in glucose use in the Zona 
Incerta by 116 + 7^ at 10 mg/kg (p<0 = 05), nucleus reuniens 
by 68 + 3% at 10 mg/kg (p<0o05) and the periventricular 
nucleus of the hypothalamus by 2? + 2^ at 10 mg/kg (p<0o05)c 
üimilarly, C.P.P. also produces increases in these areas and 
additionally in the lateral habenular nucleus. (25 + 4^ at 
2.5 mg/kg : p<0o05). (Pig. 15)
Quipazine and C.P.P. also produced marked decreases in 
glucose utilisation in the lateral, anterior ventral and 
anterior medial nuclei of the thalamuso C.P.P. also 
produced a marked decrease in the glucose metabolism of the 
median forebrain bundle whilst quipazine was relatively 
inaffective in this structure. (Pig.11, Tables 9 and 11)
5.3 .3. Limbic Areas
Quipazine produced no change in the pattern of glucose use 
in subcortical limbic areas 1 mg/kg. Even at 10 mg/kg 
only the dentate gyrus molecular layer of the hippocampus 
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Figure 11. Log dose-response curves to quipazine and C.P.P. 
thalamic areas. Results are given as percent change from 
saline control values. Quipazine was administered in doses 
of 1, 3 and lOmg/kg and C.P.P. in doses of 0.8, 2.5 and 8.0 
m^kg. *p:<0.05. Statistical analysis by ANOVA and Scheffe 
with respect to saline controls*
f  ^
u.se fnllov/inv quipazine. The dentate gyrus, nucleus 
accumbens, anterior amygdaloid area and ventral tegmental 
area all show sensitivity to C.P.P, treatment across the 
d r-'se range used.
The hipnocamnus (molecular layer), medial amygdaloid 
nucleus and the sent^l nucleus are comparatively resistant 
to C.P.P. pretr^stmenti (Pig.12; Tables 9 and 11)
5 0 3 0 ^ 0 Pxt^aryramidal Structures
Pillowing C.P.P. and ouipazi.ne administration there is an 
interesting dose-drrendant effect on the aluccse use of 
the caudate nucleus and substantia nigra. In the caudate 
nucleus, although the body and dorsomedial portion of this 
structure remain relatively unchanged at all doses of 
auipasine or C.P.P., g"' ucose utilisation in the caudal
sort ion of th'^  caudate nr clous is reduced significantly 
in a dose-dependant manner. The ventr orried ia.l portion has 
a decreased glucose use at a. dose of 3 mm/kg of quipazine 
but has increased ' ucose catabolism at 10 mm/kg of 
ou.ipazine. The effect of C.l^.P. is to nroduce a similar 
pattern ir thnt at 2,5 mg/kg the glucose utilisation in 
the ventromedial caudate nucleus is decreased and at 
R mg/kg T t is abnve control i.evels, but not significantly 
so. (Pig. 13 and 14)
Similarly, the substantia n i gr r, (rare comnacta) disnlays 
dose-dependant reductions in giucnse utilisation following 
'^ .P.'!u and quirazine. The pars rnficulata of this structure 
has a. significantly reduced level, of glucose utilisation 
following 3 mg/kg quipazine* however, 10 mg/kg of 
quipazine, increases the r t e  of glucose use in this area*
r;i
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Figure 12. Log dose-response curves to quipazine and C.P.P. 
-limbic areas. Results are given as percent change from 
saline control values„ Quipazine was administered in doses 
of 1, 5 and lOrag/kg and C.P.P.in doses of 0.8, 2.5 and 8.0 
mg/kg. *p:<0o05. Statistical analysis by ANOVA and Scheffe 
with respect to saline controls.
At a dose of 10 mg/kg, quipazine also produced a marked 
increase in the globus pallidus, C.P.l. produced significant 
decreases in the glucose use of the substantia nigra (pars 
reticulata) at low doses but at the highest dose of 8mg/kg, 
the rate of glucose use had returned to near control levels. 
The red nucleus, inferior olive and vestibular N, have 
small, non-significant changes in glucose use following 
quipazine and are significantly decreased only at the 
highest dose of G.P.P, (Pig. 13. Tables 9 and 11).
5 * 5 . Primary Auditory and Visual Areas
Quipazine significantly decreased glucose catabolism in the 
auditory system, only at the highest dose (lOmg/kg), by 
between 17^ and 29^o Following G.P.P. treatment there were 
marked decreases in glucose- utilisation in the auditory 
areas; particularly in medial geniculate body. Both C.P.P. 
and quipazine produced pronounced changes in the visual 
system. It is noteworthy that the rank order of effect 
with either drug was visual cortex lateral geniculate 
body superior colliculus. (Tables 9 and 11)
5.3.7. Comments on Results
The qualitative observations made on the behavioural 
syndrome produced by quipazine and chloropiperzinylpyrazine 
(C.P.P.) were similar in appearance to previously published 
data. (Green et al, 1976; Clineschmidt et al, 1977). In 
no way could they be considered different from the effects 
of L.S.B. and 5 methoxy-N,N-dimethyltryptamine. (See 
Chapter IV)
There is limited data available on the effects of these 
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^i#ure 13o Log dose-response curves to quipazine and C.P.P. 
-extrapyramidal areas. Results are given as percent change 
from saline control values. Quipazine was administered in 
doses of 1, 3 and 10 mg/kg and C.P.P. in doses of 0.8, 2.5 
and B.Omg/kg. *p:<0.05. Statistical analysis hy ANOVA and 
Scheffe with respect to saline controls.
Yb
produced a profound effect on the cardiovascular 
parameters measured over their entire dose range. These 
effects were qualitatively similar to those obtained with 
the highest doses of bSh and 5 meth.oxy - N,N - 
d irne thyltryptarnine o (See previous section of this thesis). 
Blatt et al, 1979 rerouted that C.P.P. diminished cardiac 
susceptability to ventricular fibrlllatioUo This was 
thought to be due to a decrease in the flow of arrythmogenic 
sympathetic nerve traffic to the heart.
The majority of the sixty structures measured resronded to 
quipazine and C.P.P. treatment with decreases in glucose 
utilisation. In a small number of areas these piperazine- 
containing putative serotonin agonists were capable of 
producing dose-dependant increases in glucose use. There 
is little electrophysiological evidence to suuport either 
of these effects on cerebral function by quipazine and C.P.P. 
Priais, 1975, rerouted that the iontophorectic arnlication 
of quipazine onto brain stem neurons in the rat had little 
direct effect but rrolonged the actions of serotonin. This 
evidence supports the view that both quipazine and C.P.P. act 
in an indirect manner by blocking the uptake of serotonin at 
the synapse (llamon et al, 1976: Clineschmidt et al, 197Baob.
and also by an increase in the release of serotonin from the 
nerve endings (Clineschmidt, 1979; Harnon et al, 1976.) 
However, there is good evidence that both quipazine and 
C.P.P. inhibit the binding of ^H-5HT t^  ^ cell membranes 
(Clineschmidt, 1979; Puller et al, 1978; Nelson et al,




Pigure 14- A utoradiographs at the level of the caudate 
nucleus illustrating the effects on this structure of 
quipazine treatment. The optical density is directly 
related to local cerebral glucose utilisation. A: In the
saline control the caudate nucleus is seen, in the coronal 
plane, as a dark relatively homogeneous oval structure*
B: This hemisection was obtained from a rat treated with
3mg/kg of quipazine. The ventromedial portion of the caudate 
nucleus has a lower optical density than the saline control, 
A. G: This coronal hemisection was obtained from a rat
treated with lOmg/kg of quipazine. The ventromedial portion 
of the caudate nucleus has now a much higher optical density 
than either A or B* key:- Con* - ventromedial caudate nucleusc
%
fact that quipazine still displaces H-5HT following the 
intracerebroventricular injection of 5, 7 - dihydroxy- 
tryptamine given in a dose sufficient to destroy the 
serotonin neuronal processes. (Nelson et al, 1978)* 
Therefore, it is likely that quipazine and C.P.P. have 
both direct and indirect effects on central serotonin 
systems.
Whatever the means by which quipazine and C.P.P. have 
their effect, the similarity of the effects of these two 
compounds on local cerebral function are apparent* 
Wuipazine and C.P.P. produce similar parallel decreases in 
glucose ree in cerebral cortex and in sub-cortical limbic 
areas; results which resemble those obtained with LSD and 
5MeO. (previous section of this thesis) What is 
different with the responses to quipazine and C.P.P. 
administration is the patterns of functional activity 
obtained in the extrapyamidal and diencephalic groups 
of structures*
The decreases in glucose use in the substantia nigra 
and the ventromedial caudate nucleus obtained with 3 mg/kg 
of quipazine and 2.5 mg/kg of C.P.P. compare favourably 
with, the electrophysiological findings which show that 
stimulation of the raphe nuclei or iontophorectic 
administration of 5HT produces an overall■decrease in 
the firing rate of these structures* (Pray et al, 1976; 
Pray et al, 3 978, Miller et al, 1975; Olpe and Koella, 
1977). The increases in glucose utilisation obtained by 
quipazine administration at 10 mg/kg are not so easily 
explained. Although there is evidence that electrical
'iO
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Plgure 15. Autoradiographic impressions at the level of the 
anterior thalamic complex* The optical density is directly 
related to local cerebral glucose utilisations. A: Whole 
section from saline control rat. B ; An enlargement of the 
thalamic area depicted in A, The anterior ventral and 
anterior medial nuclei form a U-shaped area which is darker 
than the surrounding thalamus* G* The anterior thalamus 
at the same level as B. Following 50 ug/kg of L.S.B. Note 
the homogeneous nature of the pattern of optical density 
as compared to B* B: The anterior thalamus at the same
level as B following quipazine (3mg/kg) administration* A 
different pattern of response has ensued* The anterior medial 
and anterior ventral nuclei have clearly decreased glucose 
use as compared to surrounding thalamic areas* The very 
dark area corresponds mainly to the n. reuniens but also 
includes elements of the zona incerta. Thus, saline, L.S.B. 
and quipazine treated rats have different patterns of 
response in the anterior thalamus* Key;- V-anterior ventral 
thalamic nucleus. M - anterior medial thalamic nucleus, 
r - nucleus reuniens* z - zona incerta*
stimulation of the dorsal raphe nucleus can lead to 
excitatory postsynaptic potentials, these were 
invariably followed by an inhibitory post-synaptic 
potential. (Van der Maelen et al, 1979)° It should 
also be noted that although the ventromedial caudate 
nucleus, the globus pallidus and the substantia nigra 
(pars reticulata) show increases in glucose use at 
10 mg/kg quipazine, the substantia nigra (pars compacta) 
still has a significantly decreased level of glucose 
use. Although there is no way of establishing the 
mechanism of this effect several factors may play a 
part. There are multiple inputs by serotonin fibers 
from the raphe nuclei intn the caudate nucleus, substantia 
nigra and globus pallidusa (Azmitia and Segal, 1978;
Dray et al, 1978; Miller et al, 1975). The effects 
of quipazine and C.P.P. may be subtly different in a 
dose-dependant manner on these synapses. Another 
possibility is that the change in effect is due to the 
fact that only at the highest doses used are quipazine 
and C.DoP. capable of producing a decrease in the 
functional activity of the sensory-motor cortex. Since 
this is the highest integrating centre for motor control 
(Nauta and homesick, 1979) it might be hypothesised that 
a direct inhibition of this area by these.compounds 
might release sub-cortical motor control areas from its 
inhibitory influences (Scatton et al, 1982)* This 
would mean that these particular serotonin agonists 
produce a change, not simply in the individual areas 
making up the extrapyT-amidal and motor areas, but in the 
integration of this system as a whole.
A third possibility is of course, that at high doses
ciiipazine and C.l-.P. interact with receptors other
than 5HT receptors; in particular dopaminergic
binding sites ( Cl ineschrnid t , 1979; Crabowska et a].,
1974). However, the interpretation of this data is
difficult given the afferent (Azmitia and Segal, 1978:
Dray et al, 1978) and efferent (Stern et al, 1979;
Saisi et al, 1977) connections of the dopaminergic-
containing cell bodies of the substantia nigra and
the serotonergic cell bodies of the raphe nuclei.
Furthermore, C.P.P, and quipazine in vitro fail to 
z
displace H - N,N - proplynorapomorphine from its 
specific binding sites in the rat (Luscombe et al,
1982)o The possibility that C.P.P. and quipazine 
are producing t-'ese effects via receptors other than 
5HT receptors, cannot however, be wholly discounted.
The actions of quipazine and C.P.P. on diencephalic 
structures v/a.s to produce a dichotomy in the pattern 
of resronse (Tables 9 and 11)o What mechanisms might 
underly such an effect? It can be seen that those areas 
which show a, decrease in glucose utilisation or are 
unaffected by quipazine and C.P.P. treatment fall 
into the category known as specific thalamic nuclei. 
(Donaldson et a], 1975) so called because th^y relay 
information from sub-cortical structures such as the 
cerebellum, basal ganglia and sensory p-'u:;terns to 
specific areas of cortex. These areas according to 
Azmitia and Segal, 1978 a.nd dteinbusch, 1981 have only
sparse serotonergic innervation, yet functional activity 
of the lateral thalamic and the anterior thalamic nuclei 
are markedly affected by C.P.P. and quipazine administ­
ration, This may be explained not only by direct actions 
of the putative serotonin agonists but also by the effects 
of these drugs or. input areas to these structures, e.g. 
basal ganglia, cortex, etc. (Ceman and Innes, 1965)=
The areas of thalamus showing increases in glucose 
utilisation , the zona incerta and nucleus reunions are 
termed non-specific thalamic nuclei. They project to a 
number of area.s in the cortex and thalamus (Schiebel and 
Schiebel, 1967) the hippocampus (Herkenham, 1978) striatum 
(Pov.'ell and Cowan, 1956) and the globus pallidus (Nauta
and Mehler, 1966). These areas are also capable of
producing a strong recruiting response in both thalamus 
and cortex and have a marked effect on electroencephalo- 
graphic arousal, (Moruzzi and Magown, 1949; Jasper, 1949) 
Of importance to this study is that these areas also 
receive the highest concentration of serotonergic input
to thalamic areas, (Azmitia and Segal, 1978; Steinbusch,
1981).
This does not, of itself, explain the increases in glucose 
use in the nucleus reunions and zona incerta but it is 
further evidence that those effects produced by C.P.P. 
and quipazine seem to coincide with known serotonergic 
pathways,
To summarise, these two putative serotonin agonists which 
bear a close structural resemblance to one another, 
produce similar patterns of response in the cerebrum.
It can be seen too that the spectrum of changes in 
functional activity produced by C.P.P. and quipazine are
different from those elicited by L.S.D. and 5 methoxy- 
N,N - dimethyltryptamineo This will be discussed further. 
(See Discussion and Synthesis)
In summary, quipazine and C.P.P. produced both decreases 
and increases in local cerebral glucose utilisation. Areas 
which were sensitive to the administration of low doses 
of these drugs were as follows
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VI. THE ACTIONS OF PUTATIVE SEROTONIN ANTAGONISTS 
ON LOCAL CEREBRAL GLUCOSE UTILISATION.
6.1. Behavioural Effects
Careful observation of the rats,before and after the 
administration of putative serotonin antagonists 
methysergide and metergoline, failed to detect any 
overt changes in behaviour. Cyproheptadine at the 
highest dose used, 1 mg/kg, did rroduce a short-lasting 
effect which might be described as a Straub tail effect. 
The behaviour of all rats was apparently 'normal' by the 
time of study,
6 .2 0 Cardiovascular Effects
Methysergi.de (5 and 15 rng/kg) and metergoline (0.3 and 
3 mg/kg) did not produce any significant changes in 
heart rate or blood pressure other than minor fluctuation 
during the injection time. (Tables 14 and 16) Cyprohenta 
dine produced a definite decrease in mean arterial blood 
pressure of 6 + 2^ o ( p < 0.05 : n = 6) which lasted for 
2 - 3  minutes after the cessation of the intravenous 
administration, (Table 12) The blood oressure and heart 
rate of all rats was not significantly different from 
saline control animals oi" pre-administration values at 
the time of study,
6,3 0 Local Cerebral Glucose Utilisation 
Methysergide at a dose of 5 mg/kg and metergoline at a 
dose of 0.3 mg/kg did not produce any significant effects 
on local cerebral glucose utilisation in the sixty areas
measured. Cyproheptadine rroduced almost identical 
responses at 0.1 mg/kg and 1,0 mg/kg, Therefoie, for 
ease of presentation the data will be presented only 
in terms of methyseraide (l5mg/kg), metergoline (3 mg/kg) 
and cyproheptadine (1 mg/kg). 1 other relevant data are 
available in T'^bles 13, 13 and 17 =
6 . 3 .1o Cortical Areas
The rank order of percentage decreases in cortical glucose 
use V/8S similar to that seen with serotonin agonists (see 
chapters* I V  and V . )  The py?'if orm , prefrontal and
cingulate cortices were particularly susceptible to 
treatment by metoysergide , (15 rng/kg) and metergoline
(3 m.--/kg). A'] 1 these structures had significantly
decreased rates of glucose use, lesser decreases were 
seen in the sensory-motor cortex. Interestingly, from 
the data given in tables 1C and 17, the entorhinal cortex 
was much loss affected by those nuta tive serotonin 
antagonists than c L S D ,  5MeO , Wui nomine C.lwF,
Cyorohentad i ne ^ednced tho l.ovel of r^ucose use in all 
cortical areas ncosnwed at a dose of 1 mg/kg, (Y^hles 13,
1 5 , in nrri Fig, 1.6) 
b . 1, , Diencenh^iic iro.as
'■U?thypoT-r-pdo ( 1 g g/hg 1 , V , ) T'vofirccs simnifica^t decreas-s 
in t h r a t e  of gir'cose use in tho ending nnd vo-rtroi 
anterior L^ ag arr:r , latéral t 1 ami.c nnclon.r and median 
forebrain bundle of IS-lSt. Comparatively smaller non- 
signiticnrt do^rcaeee ooonr in the eni thalamus ( h be nul a , 
subthalamic nucleus) and else v;here i n thalamus and 
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C O R T I C A L  A R E A S
Figure 16, The pattern of response produced hy methysergide 
(15mg/kgj, metergoline (3mg/kg) and cyproheptadine (img/kg) 
in cortical areas. Results are given as percent difference 
from control, *p:<iQo05o Statistical analysis by ANOVA and 
and Scheffe.
J.U3
Metergoline (3 mg/kg) oouses decreased glucose utilisation 
i.n the ventrolateral thalamic nucleus, medial hypothalamic 
nuclei, of between -17^ and -19/ ( u < 0o03). All the other 
structures have non-simnifleant changes in vlucose use of 
between -3/ and -10/.
Cyproheptadine reduces glucose use significantly in all 
the thalamic areas measured n- between -16/ and -29/=
( P < 0 , 05 ) 0 T'up erithal^mic and hyrothalamic regions 
display chaumes of +3/ to -6/, (Tables 13, 15, 17 and 
Fi^. 17)
6.3.3= Limbic Areas
Following treatment by methysergide (15 mg/kg) there are 
significant decreases ir glucose utilisation of between 
-17% and-32/ (p<0,05) in the ventral tegmental ^reas 
the dentate myrus, the anterior amygdaloid area, nucleus 
accumbens and hincocamrus (molecular layer). It a^so 
produced small decreases in glucose use in the medial 
and latera" swg'tal nud eus and the medial nucleus of the 
amygdala of -Ih to -7/r
At this dose of me tergeline (3 ng/kg) only the r^gp^ior 
amygdaloid area, the ventral tegmentoi créa and the dentate 
ryvrus were significantly different from saline control 
values by -19/ to -20/. ( p < 0,05) There is no clear 
demarcation since the areas which do not show significant 
changes still have their rates of a lue ose a.se decreased 
by between -13/ and ITfi.
Cyproheptadine (1 mg/kg) administration led to decreased 
glucose metabolism in the ventral tegmental area, dentate 
gyrus, anterior amygdaloid area and molecular layer of the 




-^Toheptadine (img/kg)' nercent differenc 
- ANOVA and
3 0  j
D IE N C E P H A L IC  A R E A S
17, The pattern of response pi^
,15mg/^g7 , metergoline (3mg/kg) and cypro. in diencephalic areas. Results are given as p^ _ 
from controls *p:<C0o05. Statistical analysis by
Scheffe*
the level of saline controls. The nucleus accumbens, the 
medial nucleus of the amygdala and the medial and lateral 
septal nucleus were minimally affected by cyproheptadine 
by between +2/ and -9/. (Tables 13, 15, 17)
6 o 3 . 4 o Extrapyramidal Areas
The most affected areas following methysergide (15 m.g/kg) 
treatment were the substantia nigra (pars compacta and 
pars reticulala) and the caudate nucleus (body, ventromedial 
and cpudal portions.) These structures showed significant 
decreases of between 17/ and 33/ (p<0o05)o The other 
extrapyramidal areas showed decreased rates of glucose 
use of between 12/ and 17/w
With metergoline (3 mg/kg) treatment significant decreases in 
^ucose use-were found in the substantia nigra , pars 
reticulata but not the pars compacta of this structure ; also 
the gl.obus pallidus, the caudal and ventromedial portions 
of the caudate nucleus but not in the body or the 
dorsolateral parts of the caudate.nucleus *
The substantia nigra (pars compacta and ps.rs reticulata), 
the caudal caudate nucleus, red nucleus, inferior olive 
and vestibular nucleus all have decreased rates of glucose 
utilisation following cyproheptadine (1 Tüg/kg) t^^atment 
which are -18% to -30% (p<0o05) bel oi' sal inu control values, 
îïon-signifleant changes of between -13/ and -16/ are found 
in the dorsolateral, body and ventrolateral portion of the 
caudate nucleus and the globus pallidus^ (Tables 13,15 and 
17).
b .3 o 5 o Primary Visual and Primary Auditory Systems 
There is an obvious difference in the way in which 










M e t h y s e r g i d e
- 1 0
-20
^  - p <0 05




C y p r o h e p t a d i n e
V I S U A L  AND A U D I T O R Y  A R E A S
Figure 18* The pattern of response produced by methysergide 
(15mg/kg), metergoline (3mg/kg) and cyproheptadine (Img/kg) 
in primary visual and primary auditory areas. Data are 
presented as percent difference from saline controls* 
*p:<0o05o Statistical analysis by ANOVA and Scheffe*
I■utilisation in visual and auditory systems o All the 
visual areas have si -nificantly decreased rates of 
glucose use fallowing treatment with decreases ranging 
between -19^ Rnd -?S% (p<OnOS)o The auditory 
systems are not significantly changed with effects 
on glucose use of between +àfo and -ll^ o^ Metergoline 
(3 mg/kg) produced no significant changes in either 
visual or auditory systems. Cyproheptadine (l mg/kg) 
reduced glucose use significantly in all visual areas 
and also in auditory cortex, (Tabl.es 13,15 and 17 
and Figo 18)
6.3.6c Hindbrain Areas and Myelinated Fiber Tracts 
Methysergide (15 mg/kg) and cyproheptadine (1 mg/kg) 
produce significant decreases in the raphe nuclei. 
Cyproheptadine also produces significant decreases in 
the rate of glucose use in the cerebellar nuclei. 
Metergoline (3 mg/kg) produces no significant changes 
in any of the structures measured in this categoryo 
There were no significant changes in glucose use in 
any of the fiber tracts areas produced by any of these 
putative serotonin antagonists. (Tables 13,15 and 17)
6.3.7, Comments on Hesults
The lack of behavioural effects displayed by the putative 
serotonin antagonists is in line with the' findin.g of a 
recent comprehensive study of their effects on rat 
behaviour. (Green et al, 1981 )<,
In a similar fashion, the laclp of effect of methysergide, 
metergoline and cyproheptadine on blood pressure and heart 
rate is in keeping with the previously published d a. t a «
These putative serotonin antagonists have been shown 
to have little or no action on blood pressure and heart 
rate in normotensive rats* However, they block the blood 
pressure increase produced by the intracerebroventricular 
administration of 5HT. (Lambert et al, 1975; Lambert et 
al, 1978; Smith and Struyker-Boudier, 1976; Wolf et al,
1981)o
The major action of these compounds was to produce a 
decrease in the level of cerebral functiono However, it 
is apparent that while the pattern of response to methy­
sergide (15mg/kg) and metergoline (3mg/kg) was similar, 
the actions of cyproheptadine produced quite a different 
pattern of responseo This was seen, particularly in the 
cortical structures where cyproheptadine (img/kg) produced 
significant decreases in glucose use in all of the cortical 
areas measured. (Tables 13, 15 and 17. Fig. 15)
These results are of particular interest in two respectso 
The first is that these putative serotonin antagonists 
affect local cerebral glucose utilisation in a manner 
similar to putative serotonin agonists* The second, that 
there are greater similarities between the responses to 
methysergide and metergoline than there are between these 
compounds and cyproheptadine *
The depressive effects on local cerebral function are in 
keeping with the electrophysiological data of Haigler and 
Aghajanian, 1974 who found that methysergide, metergoline and 
cyproheptadine inhibit the firing rate of cells in the brain 
when given alone and enhanced the inhibitory actions of
5HT. A similar inhibitory action is seen in studies 
on cat spinal cord, (Gilbey et al, 1981; Proudfit 
and Anderson, 1973). Does this mean that these 
compounds which are potent antagonists of 3HT actions 
in a number of peripheral systems (Brownlee and Johnston, 
1963; Day and Vane, 1963; Gaddum and Ficarelli, 1957; 
Muller-Üchweinitzer, 1980; Porquet et al, 1982; Roch 
E Silva et al, 1953; Sakai et al, 1979; Goodman and 
Gilman, 1970 for review) are agonists in tl.e central 
nervous systems?
The situation is. much more complex * Firstly, metergoline 
blocked the effects of 5HT in the cortex (Sastry and 
Phillis, 1977), methysergide and cyproheptadine block 
some, but not all,of the inhibitory responses to 5HT 
in the hippocampus (Segal 1975; Segal 1976) and these 
drugs block the 5HT-induced facilitation of the firing 
rate of facial motoneurones (McCall and Aghajanian, 1979; 
Van Per Maelen and Aghajanian, 1980). Thus, there is 
evidence of antagonism of at least some central 
serotonergic actions by these compounds. (This will be 
discussed more fully in the next section)*
Secondly, there is in vitro evidence that putative 
serotonin agonists and antagonists bind to different 
serotonin binding sites or different forms of the same 
receptor* (Rennet and Snyder, 1976; Enjalbert et al, 
1978; Nelson et al, 1978; Nelson et al, 1979), Thus, 
although LSD, 5MeO, C.P.P. and quipazine on one hand, and 
methysergide, cyproheptadine and metergoline on the other, 
produce decreases in glucose utilisation in the rat brain, 
they may be acting by different mechanisms. (As will be
seen in the next section of this thesis, metergoline (3mg/kg) 
and methysergide (15mg/kg) interact in an interesting manner 
with putative serotonin agonists*)
As mentioned above, the pattern of response produced by 
cyproheptadine was different from that following methysergide 
and metergoline treatment* Since this compound is nearly 
as potent on histamine receptors as on serotonin receptors 
(Stone et al, 1961) this may be due to the action of this 
drug on systems other than serotonergic ones* For this 
reason, and due to the fact that this compound has been 
shown to poorly block the actions of serotonin agonists 
(Green et al, 1981) it was used no further in these 
experiments o
In summary, methysergide (l5mg/kg), metergoline (3mg/kg) 
and cyproheptadine (img/kg) produced decreases in local 
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VII, THE EFFECTS 0? METIIYSERGIDE ON THE ACTION 0?
PUTATIVE SEROTONIN AGONISTS
7 olo Behavioural Effects
Prom qualitative observations only, this dose of methy- 
sergide (l5mg/kg) was capable of blocking or attenuating 
behavioural effects produced by L.S.I). (l5ug/kg) 5MeO 
(750ug/kg), quipazine (3mg/kg) and G o P o k .  (2.5mg/kg)o 
There was some hyperactivity and increased sniffing 
following agonist administration but this was not as 
marked as could be observed following the agonist aloneo 
These effects were also of short durationo
7 o 2 o Cardiovascular Effects
As has been described previously the putative agonists
reduce heart rate from saline control values; L.S.B. at
a dose of 15 ug/kg does not do this significartlyo
in
However, the overall effect was the reduction heart rate 
of between 6^ and 25^ (Pig. 19, Tables 18,20,22,24). LSD 
administration produced little effect on mean arterial 
blood pressure. Quipazine (3mg/kg), 5MeO (750 ug/kg) 
and C.P.P, (2.5ng/kg) increased mean arterial blood 
pressure by between 18/ and 35/. (p<0o05). (Pig. 20)
7.3 o Local Cerebral Ulucose Utilisation
7.3.1. Cortical Areas
In the cortical structures measured, methysergide (I8rng/kg) 
did not block any of the responses to LSD (15 ug/kg).
There wa8,however, a significant increase in the effects 
of LSD on glucose utilisation in the pyriform cortex from 
-20 f 5/ (p<0.05) with LSD alone to -54 + 6/ (p<0.05) 
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other cortical structures there was a tendency for 
methysergide pretreatment to increase the LSD - induced 
changes in glucose utilisation.
Methysergide hioeked or attenuated decreases in the 
rate of glucose use elicited by 5NeO (750 ug/kg) in the 
perietal cortex, ryritorm cortex, frontal cortex, 
anterior and posterior cingulate cortices. For examle, 
in the anterior cingulate cortex, IMeO alone decreased 
glucose use by -26 j_ /|/ (p-^  O.05). In combination with 
methysergide there was a 9 + 4/ increase in glucose 
utilisation. (Fig. 21) In the other cortical structures 
the pre-administration of methysergide had no effect on 
the 5MeO-induced response of glucose utilisationo 
Quipazine (3mg/kg) produced significant decreases in 
glucose utilisation in 6 our of 9 cortical areas measured.
Of these, the pre-aaministration of methysergide blocked 
or diminished the response to quipazine in all but one 
area, the entorhinal cortex.
The actions of O.P.P. (2.3rng/kg) on cortical glucose
utilisation were wholly or partially blocked by methysergide
only in the anterior and posterior cingulate cortices. The
other cortical structures respond in a similar manner to
C.P.P. whether alone or in combination with methysergide.
I
(Tables 19,21,23,25: Fyg, 21)
7 . 3 0 2 o Dienceuhalic Areas
Methysergide blocked or attenuated the LSD - induced 
decreases in glucose utilisation in the ventral ^nd medial 
portions of the anterior thalamic nucleus, the lateral 
thalamic nucleus, the lateral and medial habenula and 
the zona incerta. (»Tabi,e 19)
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Figure 21. The effect of methysergide (I5mg/kg) pretreatment 
on the response of glucose utilisation in the anterior 
cingulate cortex to the administration of putative serotonin 
agonists: L.Ü.D. (l5ug/kg); 5MeO (750ug/kg); quipazine (3mg/k, 
and C.P.P. (2.5 mg/kg). *p:<0o05 with respect to saline 
controls. Statistical analysis by ANOVA anc^  Scheffe.
Tn th^ diencephalic ^recs which responded significantly 
thFicO alone, the p^etrectnent of methysergide blocked 
or reduced the effect of t^is drug on glucose use. These 
changes were + i cularly noticesh^e in anterior ventral 
thalamus v/here fMeO '^ime p].icited a 28 + 7/ (p<Oo08) 
decrease in glucose use but in combination with methy­
sergide the response wos only -5 e- 6/. (Table ?1 ;
3?)
I'ke anterior ventral end a n t i o T  mrodial ro^t^ens nf the 
thalamus hnvp sirni f i c^ntly d ecu fussed levels ef uincose 
upe following '^ iwr'ezine treatment. These areas showed 
no significant changes in glucose utilisation following 
methysergide pretrcatm.ent unlike the lateral, thalamic 
nuc^pus ■'■/here methysergide had. ne e■^ 'f"ct on the resnonse 
to cuipaz'^ .ne. The nucleus reunions and ueriventricular 
nucleus of the hypothalamus whore ouipazine produced 
inc^nases in glucose use also failed to rcsuond si.^nifi- 
cpp+ly to tcis drug following m^thyseumide administratiouo 
(Table ?8)
'iothyserui_de b l o r  diminished the pf'fects of C.P.P. 
on the ratus oh gi.ucose use in all tho areas v/hich. respond 
significantly to this drug aloneo The one exception to 
this bein.g the ventrolateral nucleus of the thalamus where 
the resnons® to C.n.P. administration was ■approxim'^tely the 
same who then given ai_ona or- in combination with m^thyseuogdo 
C.P.P. alone increased glucose use in the medial habenula 
by 3 4- 1/, Pol low in.a- methysergide administration C.p.p, 
reduces the rate of glucose use in the medial habenula by 
18 j- 4/ (p <n„ Ob) .
^ 8 3 , Limbic Areas 
hethysergi ri e/
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Figure 22, The effect of methysergide (l5mg/kg) pretreatment 
on the response of glucose utilisation in the anterior 
ventral thalamus to the administration of .putative serotonin 
agonists: L.S.D» (I5ug/kg); 5MeO (750ug/kg) quipazine
(5mg/kg) and G.l.P. (2^5 mg/kg). * p:<0o05. with respect to 
saline controls, statistical analysis by A^OVA apd Scheffe.
Methysergid-j ( 15i'ig/kg) affected the l^mMc responses to 
LSD (15 uy/kg), in the nucleus accnmhens, dentate gyrus 
and the ventral tegmental area; where the effects of 
LSD on glucose utilisation are reduced hy methysergide 
pre-administration^
5KeO (750 ug/kg) on the other hand, significantly reduced 
nlucose utilisation in all the limhic areas. These effects 
are all blocked by methysergide, with the exception of the 
ventral tegmental area.
iuipazine only produces significant changes in glucose 
utilisation in one limbic area, the dentate gyrus at this 
dose (5mg/kg) where a decrease in glucose utilisation was 
unaffected by methysergide administraiion, (Fig, 25) 
Significant reductions in glucose use were found in the 
dentate gyrus, medial septal nucleus, nucleus accumbenSp 
anterior amygda.loid area and ventral tegmental area 
following C.P.l. (2.5 mg/kg) administration. Of these, 
the responses of the medial septal nucleus and nucleus 
accumbens, were blocked and those of the dentate gyrus, 
anterior amygdaloid area and ventral tegmental area were 
unaffected by methysergide prc^trea tnen t. (Fig, 21 ) 
Furthermore, the hirnocampus (molecular layer) which shows 
a -9 + 5/ decrease in glucose use followinv C.P.L. alone, 
nov/ demonstrates a Q + 3% ( p <0,05) decrease in the -rate 
of glucose u.tilisotion followinm C.P.P. and methysergide, 
7.5.4. F X t, ran r a m i d a 1 ir e a s
LSD (15 ug/kg) uroduoed significant decreases in glucose 
use in the four portions of caudate nucleus measured and 
the substantia, nigra, pars compacta and pars reticulata. 
howr;ver , whi 1 st methysergide (l5mg/kg) blocked cornrletely
14U
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Figure 23 o The effect of methysergide (l5mg/kg) pretreatment 
on the response of glucose utilisation in the dentate gyrus 
to the administration of putative serotonin agonists: LSD 
(15ug/kg); 5HeO (750ug/kg); quipazine (^mg/kg) and C.P.P. 
(2,5mg/kg)o * p:-<0o05o with respect to saline controls* 
Statistical analysis by ANOVA and Scheffe*
the actions of LSD on the dorsolateral, central, 
ventromedial and caudal narts of the caudate nucleus,
It failed to affect significantly, the responses of the 
substantia nigra, to LSD treatment*
LMeO (750 ug/kg) induced large significant decreases in 
glucose use in all the extra.pyramidnl structures measured* 
With the execution of tha vestibul.ar nucleus which is 
una.f .f ected, a.l 1 these resuonses are blocked or ^educed 
by methysergide pretreatment *
Onipazine (dmg/kg) significantly deo^nased the rate of 
glucose use in only two areas of the caudate nucleus, 
ventromedial and caudal, and the substantia nigra, pars 
comnacta and r eticulatao None of those responses were 
markedly affected bp methysergide treatment *
C.l'.P, ( ? . 5 mg/kg ) produced a very similar pattern of 
resnonse in the caudate nucleus and subs tant i a nigra as 
ouipazine0 Methysergide did not seriously affect any 
of these act ions of C.P.P. However the inferior olive 
had a decreased rate of glucose utilisation of -11 + 
following C.P.P'. alone and a decuease of + 5/ (p-<0.05)
following C.P.P.'and . methysergide* (Tables 19,71,25,
25; Pig. c/i)
7.5.5^ Primary Visu-^ 1 and Primary Anditony Areas 
LCD (id u.g/kg) affpct“d only one a r e - ^ ou and i i-ory function 
significantly; th'^  nucleus of the lateral lemniscus* 
Methysergide had no effect on the response of this structure 
to LCD. However, it increased to significant levels the 
responses of auditory cortex and superior olivary nucleus.
In contrast, LSD reduced glucose utilisation in all of the
±4 ci
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Figure 24. The effect of methysergide (l5mg/kg) pretreatment 
on the response of glucose utilisation in the caudate nucleus 
(ventro medial) to the administration of putative serotonin 
agonists: L.S.D. (I5ug/kg); 5MeO (750 ug/kg); quipazine
(3mg/kg) and C.P.P. (2<,5mg/kg). *p: <0<,05o with respect to 
saline controls. Statistical analysis by A'^OYA and Scheffe,
primary visual areas measured. Metfiysergide blocked all 
of these effects,
5MeO decreased the rate of glucose u-^ e significantly in 
the medial geniculate body and la teral lemniscuso These 
responses are blocked, and unaffected, respectively by 
methysergide administration. In primary visual a^eas 
5MeO reduced glucose utilisation in the superior colliculus 
and lateral geniculate body but not visual cortex, 
Methysergide blocked completely the actions of ?MeO on 
the superior colliculus and the dorsal portion of the 
lateral geniculate body but had no effect on the 5MeO 
induced response of the ventral part of the lateral 
geniculate body,
Quipazine had only minimal effects on the glucose 
catabolism of the primary auditory areas at this dose, 
Quipazine did, however, reduce glucose use in visual- 
related cortex, lateral geniculate body and the superior 
Golliculus (superficial layer)a This latter effect was 
not blocked by methysergide but the actions of quipazine 
on the rate of glucose use in the visual cortex and 
lateral geniculate body were reduced to nonsignificanceo
CoP.P.(2o5 mg/kg), unlike the other agonists used, reduced 
glucose use in all of the primary auditory areas with the 
exception of the inferior coll.iculus. Methysergide had 
no effect on any of these responses. Of the CoP.P, - 
induced effects on the visual system, only the response 
of visual cortex was blocked by.methysergide,
7.3o6. hindbrain Areas
LSD produced significant changes in the level of glucose
use only in the dorsal and median raphe nuclei. These 
responses were unaffected hy methysergide administration.
5MeO produced significant decreases in the cerebellar 
hemisphere and vermis, the pontine reticular formation, 
and the median and dorsal raphe nuclei. Only the effects 
of 5MeO on the cerebellar hemispheres were blocked by 
methysergide pre-administration. The rest were unaffected, 
Ouipazine produced no significant changes in glucose use in 
any of the hindbrain areas. The combination of quipazine 
and methysergide did, however, produce a decrease in pontive 
glucose utilisation of-20+ 3/ (p<C0o03)v C.P.P. produced 
significant decreases in the glucose utilisation of the 
dorsal and median raphe nuclei which were unaffected by 
methysergide administration,- 
7 o3 o 7. Myelinated Fiber Tracts
In these areas LSD, quipazine, C,P.P. and methysergide 
had no effects given singly or in combination. However, 
5Me0 significantly reduced the glucose catabolism of 
cerebellar white matter and the corpus callosum. Both 
of these affects were soverelv attenuated bv methysergide.
VIII. THE EFFECTS OF MET3R00LINF OH THE ACTIONS OF 
PUTATIVE SEROTONIN AGONISTS
8.1. Behavioural, Effects
The behaviour of the rats was carefully observed at 
all times following the discontinuâtion of anaesthesia.
The behaviour following the administration of putative 
serotonin agonists and metergoline have previously 
been described (see chapters IVQV and VIry of this 
thesis). The administration of metergoline (3mg/kg) 
twenty minutes prior to LSD, ?MeO, quipazine or C.P.P. 
led to a visible diminuâtion in the behavioural syndrome 
produced by these substances, particularly affected 
were the more * vivid' a.snects of the behavioural 
responses i,e, the forepaw padding and head swaying.
This dose did not however, completely block the hyper­
activity and sniffing which occurred,
8,2 o Cardiovascular Effects
Metergoline at a. dose of 3mg/kg had no significant effect 
on either heart rate or mean arterial blood pressure.
There was a small, non-significant, decrease following 
LCD (I5ng/kg) administration, hMeO (750 ug/kg) produced 
a 11 + 4/: (p< 0o05) decrease in heart T'été-, Quipazine 
(3mg/kg) and C.P.P. (2o5mg/kg) dramatically decreased 
the heart rate by 26 + 3i° and 20 + 7^ (p<0o05) respectively
Metergoline and LCD had very little effect on mean arterial 
blood pressure whilst 5MeO, quipazine and C.P.P. produced 
increases in blood rressure of between 10/ and 29/o
14b
Metergoline (3mg/kg), although having no intrinsic 
effect on heart rate and hlood pressure, blocks the 
actions of the serotonin agonists on heart and blood 
pressure, (Tables, 26, 28,30,32)
8,3c LOCAL CEREBRAL GLUCOSE UTILISATION
8,3,1. Cortical Areas
Following metergoline administration, L S L  (lb ug/kg), 
which on its own produced significant decreases in 
gi.ucose utilisation in 5 out of the 8 cortical structi.’.res , 
now nroduced decreases in all of the areas measured, 
Furthermore, there was good evidence from the data that 
the combination of LSD and metergoline potentiated the 
effects of the agonist alone. For example, in the frontal 
cortex, LSD and metergoline alone produced a change of 
5 + a/ and 5 + 3/ respectively; however in combination they 
produced a significant decrease in glucose utilisation 
of 33 ± 5/ (p<0,03)o
The interaction of metergoline and 5MeO nroduced a more 
varied pattern, 5MeO (730 ug/kg) produced significant 
decreases in glucose utilisation in 7 out of the 8 
cortical areas measured, Metergoline reduced the effect 
of 5MeO on glucose use in the frontal cortex from -28 + 1/ 
(p<0o03) to -16 + 6%o It also potentiated the effects 
of 5HeO on the entorhinal cortex by increasing its 
effects on glucose in this structure from -22 + 4/
(p<0o05) to -42 _+ 47" ( T3 0 o 03 ), In the remaining 
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response produced by bMeO,
Of the cortical structures which responded to quipazine 
(5ms/kg) administration with a significant decrease in 
glucose utilisation, two, the frontal cortex and the 
posterior cingulate cortex, showed a blockade and an 
attenuation of the response, respectively, following 
metergoline administraiiono In the other structures, 
metergoline did not significantly change the glucose 
utilisation response to quipazinco There were no 
examples of a potentiation of the quipazine responseo
Metergoline reduced the effects of C.P.P, (2.5mg/kg) 
on the rate of glucose use in the anterior and posterior 
cingulate cortices* For example, C.P.P. alone produced 
a 36 + 57° (p<OoOh) decrease in glucose in the posterior 
cingulate cortex* Following metergoline pre-treatment 
it produced a decrease of 19 + 5/ (p<0o05) in glucose 
use in this structure* In the other structuresthere was 
no evidence of potentiation of C.P.P. induced responses 
(Table 27, 29, 31, 32).
8.3o2o Diencephalic Areas
LSD produced an overall decrease in the level of ahuoose 
utilisation in thalamic and hypothalamic structures* 
Metergoline blocked this effect in only one structure, 
the medial habenula* In this structure the 22 + 8/ 
(p<0.03) decrease in glucose use produced by LSD alone 
is reduced to a 11 + 4/ decrease following metergoline* 
Metergoline administration potentiated the effect of LSD 
on the nucleus reunions from a decrease in glucose use 
of 8 + to 38 + 6/ (p<0*03), (Fig* ?b) The pattern
of response was further complicated by the fact that some 
of the effects of the combination of L.S.D, and metergoline 
were the sum total of the response to L.S.D. and metergoline 
alone* For example, in the hypothalamus, decreases in glucose 
use of 13 + 7/ and 17 + 5/ for L.S.D. and metergoline alone 
became a 29 + 7/ decrease when L.S.D* and metergoline were 
given together* There are also thalamic structures such as 
the ventrolateral thalamic nucleus which did not respond 
differently to L*S.D. following metergoline administration* 
Three diencephalic areas had their responses to 5MeO blocked 
by metergoline administration* These were the mediodorsal 
thalamus, the subthalamic nucleus and the zona incerta*
The pretreatment of the rat with metergoline led to a 
potentiation of the action of 5MeO in reducing glucose use 
in the nucleus reunions from 15 + 5/ to 29 + 5/ (p 0*05) 
as can be seen in figure 25o In the other structures which 
responded to 5MeO administration there was little effect on 
the response produced by 5MeO following metergoline admin­
istration*
Interestingly, the areas in which glucose utilisation 
increased with quipazine (3mg/kg) were blocked by metergoline 
i*e* the nucleus reunions and periventricular nucleus of the 
hypothalamus. (Fig, 26) In addition metergoline blocked 
the responses to quipazine in the anterior ventral and 
anterior medial thalamic nuclei. Metergoline did not 
potentiate the affect of quipazine in these areas*
A very similor pattern occurred when O.P.P. was {W.ven 
to metergoline-treoted rats* The increases in glucose 
use in the lateral habenula and neriventricular nucleus 
nf the hypothalamus were blocked by metergoline pre- 
treatment* The nucleus reuniens was of narticular 
interest* (Pig* 26) C.P.P. (2*5mg/kg) pronuced a 
40 + 6/ (p<O.Ob) increase in glucose utilisation*
Following metergoline, C.P.r. induced a 26 + 5/ (p<f0.Ob) 
decrease in glucose use.
The effects of C.P.P. on the rate o'" glucose use in 
the anterior ventral and anterior medi.al thalamus were 
blocked and reduced respectively by metergoline* There 
is no evidence of potentiation of C.P.P. responses 
following metergoline in any,of these areas* (Tables 
27, 29, 31, 33)
8.3,3 0 Limbic Areas
The administration of metergoline had virtually no effect 
on the ability of limbic areas to respond to LSL treatment, 
ilone o f  these areas d i splayed ocka.de or notentiation o f  
rlucose utilisation effects*
Similarly, the pattern of response pr^duc^d by 5PieO on
glucose use in these regions of the limbic system was
v^ry similar whether administered o'" one ot’ with metergoline*
Th^ r^e was evidence of tor-goi i ne potentiating the c’^ "fect 
of quipazine on iLe .-incose use of t>ie lii"^rocamnns 
(molecular Vpvc^ V, n'ulpozire ("rng/kg) decreased o rose
i;se i,n this arac y y g + 6 A toit dwnr^oned the ■^ ate of 
glucose utilisation b,- 34 + 7!^' (p<f*C6) when administ­
ered a f t e r  m") ter mol ine * The on.i structure \/hich was
significantly affected by niupazine alore, the dentate 
gyrus, resronded in a similar manner to a combination 
of metergoline and an irazine*
Metergoline blocked the actions of C.P.P. on glucose 
use in the dentate gyrus : reducing the effects frcm
“2? + A/ (n< 0 ,ois) to -16 + 57/ There is also a marked 
increase in the rppyonse of the hinnocamnus (molecular 
layer); -9 +, 5/ to -2/ + A/ ( p < 0o05). (Tables ?7,
?9, -31, ’3)
8 . 3 , A 3 uy T -r 0 nyraifi id a 1 ire a s
Three extrapyranida1 regions displayed significant 
decreases in glucose use following LSD administration; 
the substantia ndgrq (pars reticulata and pars compacta) 
and the caudal portion of the ca.udate nucleus* Metergoline 
had no effect on these responses. However, in 6 out of 
the 10 regions measured metergoline pretreatment 
•potentlated the actions of LSD* For example, in the 
dorsolateral caudate -nucleus, metergoline increases the 
effects of LSD from -17 + 77° to -3A + 6/ (p<0o05)o No
area showed a blockade of an LSD induced response by
metergoline, (Fig, 27)
Metergoline failed to block any of the responses produced 
by 5MeO in this gT-cup of structures. In only one area,
the vestibular nucleus, did this pattern ci; ange * In t i. s
structure, the response to 5MeO administration was a 
21 + 64 (p-^0o05)o Following metergoline pretreatment,
SMeO elicited a -i 6 + 'bf decrease in glucose utilisa­
tion*
The overa.il effect of a combination of metergoline and 
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Figure 27. The effect of metergoline (^mg/kg) pretreatment 
on the response of glucose utilisation in the dentate gyrus 
to the administration of putative serotonin agonists: LSD
(15ug/kg); 5MeO (750ug/kg); quipazine (3rag/kg) and C.P.l. 
(2.5mg/kg). ^p:<0.05. Statistical analysis by ANOVA and 
Scheffe.
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alucose use. For example, quipazine did not change 
the rate of glucose use in the dorsolateral caudate 
nucleus, hut the combination of metergoline and 
quipazine reduced glucose catabolism by 34 + 4^
( p < 0 o 05 ).
In the substantia, nigra and caudal caudate nucleus there 
was no a.ffect on the response' of these structures to C.P.P 
r oil owing metergoline administration. However, "i.n 
the dorsolateral and central portions of the caudate 
nucleus and in the inferior olivary comrlex and 
vestibular nucleus the combination of metergoline pre- 
treatment and CoP.P. caused a marked potentiation of 
the effect of the agonist alonco (Tables 27, 29, 31,
33)
H.3,5, Primary Visual and Primary Auditory Areas 
LvSP (15 ug/kg) nroduced only one significrnt change in 
glucose use in primary aud ilory areas of the rat brain; 
in the lateral lemniscus, However, following metergoline 
pretreatment, which itself has no significant actions 
on glucose use in these areas, all of the auditory- 
related structures show large, si,^mifleant decreases i.n 
glucose utilisation. For example, the auditory cortex 
responds to LSD treatment with a decrease in glucose 
catabolism of 12 j- Po1 1 o’-.ln/” metergoline treatment
LSD produced ° -3-i + 1'^'. de c r e a s e  in the level of glucose 
use in thi.s area. The ef'fects of LSD and metergoline on 
the visual-related areas of the^rat brain were somewhat 
more complex, V/ith the exception of the lateral 
geniculate body, whose response to LSD is unaffected* 
the visual areas a 11 shov/ an increase in their response
to L3D following metergoline administration. An almost 
identical pattern of response occured when 5MeO and 
metergoline were administered, alone and in combination.
On the other hand, cpiipazine induced only minor non­
significant responses in auditory areas whether alone 
or in combination with metergoline (with the exception 
of the superior olivary nucleus). The effect of this 
drug on structures with a visual function wa.s increased 
following the administration of metergoline,
O.f.P. (2,5 mg/kg) produced a number of significant 
decreases in glucose utilisation in primary auditory 
areas. These responses were largely unaffected or 
slightly increased by the administration of C.P.f. in 
the presence of metergoline,- The actions of C,P,P. on 
visual-related structures are, at this dose, only 
significant in the visual cortex and lateral geniculate 
body. In the visual cortex the effect of is
decreased and there is no effect on the response of 
the lateral geniculate body by metergoline pretreatment; 
8o3o6o Hindbrain Areas
With the exception of the cerebellar hemispheres, there 
was an increase in the reactivity of glucose use in 
hindbrain areas to LSD administration following 
metergoline. The pattern of glucose utilisation in 
hindbrain areas was slightly different following 5MeO 
and metergoline treatment. There was no effect on the 
response to fMeO in the cerebellar hemisnheres, dorsal 
raphe nucleus and pontine reticular formation but there 
was an increase in the 5MeO induced decrease in glucose 
utilisation following metergoline in the cerebellar 
nuclei, cerebellar vermis and median raphe nucleus,
Quipazine elicits only minor, non-significant changes 
in hindbrain areas. In the median raphe and the pontine 
reticular formation, where quipazine decreased glucose 
non-significantly alone, in the presence of metergoline 
it induced changes of -21 + li° (p<(0o05) and -29 + 4%
(p<0o05) respectively,
Metergoline increases the effects of C.P.P. on the rate 
of glucose use in the hindbrain areas measured, with the 
exception of the cerebellar hemisphere,
8.3°7 Myelinated Fiber Tracts
There were some significant effects on glucose use 
produced by the putative serotonin agonists L.S.D. and 
5MeO. These effects were blocked by metergoline pre­
treatment o
8o3o8 Comments on Results
There were similarities and differences in the patterns 
of cerebral response produced by methysergide and 
metergoline pretreatment. If we consider only the 
significant responses, methysergide (l5mg/kg) attenuated 
63^ of the L.S.D. effects, 80^ of the 5MeO effects, 52^ of the 
quipazine effects and 33^ of the C.P.P, effects on local 
cerebral glucose utilisation. In contrast, metergoline 
(3mg/kg) pre-treatment decreased 4^ of the L.S.D, effects, 
iGfo of the 5MeO effects, 22% of the quipazine effects and 
23% of the significant responses to C.P.P.
Furthermore, the combination of the antagonist and agonist 
led, on a number of occasions, to an increase in the 
action of the agonist, (i.e, a potentiation of the agonist 
effect or the summation of the actions of both agonist and 
antagonist.) Again there were differences in the resultant
interactions between the putative serotonin agonists 
and antagonistso Methysergide potentiated the significant 
response to L.S.h., quipazine and G.P.P. on 17/^ , 9^ and ISfo 
of occasions respectively. This effect did not occur with 
the combination of 5MeO and methysergideo Metergoline 
potentiated the significant actions of L.S.Do 5MeO, 
quipazine and G.P.P. in 39^» and respectively
of the structures which showed significant changeso 
The percentage of affected structures whose agonist 
response was unaffected by the administration of the 
peripheral antagonists was between 20^ and 49^ for 
methysergide, and 23fo and 45^ for metergoline pre-treatment
These data raise some interesting pointso Firstly, these 
studies show quite clearly .that methysergide and meter­
goline do not block all the effects of the putative 
serotonin agonists on local cerebral functiono Secondly, 
in some areas the combination of the putative agonists 
and antagonists leads to a summation of their individual 
effects, the potentiation of the action of the agonist, 
or even, in one structure, the nucleus reuniens (only with 
CaPoP.) a reversal of the effect of the agonist or 
antagonist alone Thirdly, the methysergide-agonist 
and the metergoline-agonist effects produced differing 
patterns of cerebral response which are difficult to 
reconcile with the fact that both of these putative 
antagonists blocked the behavioural and cardiovascular 
actions of the putative serotonin agonists in the same 
groups of rats. Admittedly the cardiovascular effects
produced by the serotonin-mimetic drugs are probably a 
complex combination of peripheral and central effectso 
(See previous sections of this thesis for discussion)o 
The hypertensive effect of the intracerebrovascular 
administration of serotonin has been shown to be blocked 
by various putative serotonin antagonistso (Antonaccio 
and Cote, 1976; Kirstic and Djurkovic, 1976; Lambert 
et al, 1975; Lambert et al, 1978)o
There have been numerous studies measuring differing 
behavioural parameters induced by alteration of central 
serotonin machanismso (Balsara et al, 1979; Chadwick 
et al, 1978; Clineschmidt and Lotti, 1974; Corne et 
at, 1963; Corne and Pickering, 1967; Costall and 
Naylor, 1975; Green et al,. 1981; James and Starr,
1980; Langlais and Gabay, 1977; Malick et al, 1977;
Vetalani et al, 1979; Weiner et al, 1975. inter alia)o 
In all of these studies known peripheral antagonists 
of 5HT actions have been used and found to block or 
reduce the serotonin mimetic effectso Prom the data 
presented here it would seem that this reduction of the 
behavioural effect is due not to a simple negation of 
the actions of the serotonin agonists but perhaps by the 
production of a different pattern of cerebral functiono 
Electrophysiological data is equivocal. Serotonin 
antagonists have been shown to block the effects of serotonin 
and serotonin-mimetic manipulations of the cell-firing 
rates of cells in a number of areas in
in th<^  brain, (Ennis et al, 1981 ; McCall and 
A; hajaniar , 1979; 91.r e and Knelln., 1977: Proudfit
and Anderson, 197A; dastry and Fhi.'^ lis, 1977; Segal 
1975: 7^n der ha el en and Agba ja nian, 198^9 i.nter
aliaW ,
Tn other studies, nuta.tive serotonin antagonists 
not nni.y had an ’agonistic' action per sc but also 
failed to block tiie depression in cell-firing rate 
r'"oduced bp serotonin itself, (Boakes et al, 1970; 
h'aigler and Àgha,lan1 an, 1.974 a,b,) although they did 
block the excitatory responses of serotonin. Furthermore, 
in the hippocampus, methysergide could block some but 
not all the inhibitory effects nf serotonin, (heaal 
1975; Segal, 1976), Thus, the electrophysiological
information available seems to run the full gamut of 
rossibil ities and in this sense is oualita ti.vei y similar 
to the complex pattern of cerebral response found in 
t'lis study.
rennet a>".d bnyder, 1 976 prop o red that se rat on in agonists 
and antagonists bind to different serotonin receptors 
or to the same receptor in different conformations. This 
v/ork has been cnnfirned and extended by a number of other
investigators (ifamnn et al, 1990; H^mon et al, I98I ;
Nelson et a 1 , 1978; h-1 son et al, 1.979: Maison et al,
1*^ 81). Te ÎQ op i n t ores t in t :i ir respect tlu't metergoline 
is a r o tent disn^acer e f ' H-'^ dïT (the ’ agoni s t site’ 1 as
- s r i r>or e r i d a’ (the ' a nta goni s. t site') a"'1;l'rnigh a
a
recent paper by Hamon et a 1 , 1981 has shown that hi - 
r-s'tarn-ni inc v/a.s poorly d ispl a: cod by 911^ , 9 rnetlioxy
N,N-dimethyltryptaraine, quipazine or trifluoromethyl- 
pheny1piperaz ine o
Biochemical evidence seems to suggest a similar dichotomy. 
Berotonin agonists all increase 5HT turnover and decrease 
5 hydroxyindoleacetic acid levels in the rat hraiuo 
(Clineschmidt, 1979; Freedman et al, 1970; Hamon et 
al, 1976; Jocoby et al, 1976; Miskiev/icz et al, 1979; 
Rosecrams et al, 1967), lutative antagonists of 
serotonin have been shown to be 1 a.rgely ineffective 
at producing changes in these parameters (D’amico et al,
1976; Jacoby et al, 1978) except at h^gh doses. (Sofia 
and Vassar, 1975 )o
This evidence taken together suggests that the putative 
serotonin agonists, LSI), 5MeO, quipazine and C.P.P., 
and the putative antagonists methysergide and metergoline 
may be acting on differing but overlapping sets of 
serotonin receptorso The combination of ’agonist’ and 
’antagonist' produces a complex pattern of functional 
response in the brain of the conscious rat.
In summary, the administration of methysergide and metergoline 
before treatment with serotonin agonists produces a complex 
pattern of response in which the effects of the agonists 
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Tlironrhnnt this text it hrs been tnXen for fronted that
alucone n t i i i s a t i o r  is eouivolent to,or is ot least a;
direct meo.anrement of cerebrol function^ V/hot evidence 
i.a their on which to base this assumotion?
The method itself has been nsed to demonstrate the close 
relationship between known physiological responses and 
those of local cerebral ylncose utilisation. Perhaps 
the most cenvinci^y example was the ratterns of local 
eerebnal yi nc'ose utilisation following visual deprivation 
in the monkey (Kennedy et al, 1975; Kennedy et al, 1976)* 
In these studies the pattern of response, following 
unilateral visual deprivation, consistently renlic^ted 
the known uhysiolo pical and anatomical properties of the 
ocular dominance columns of Hubei and \/iesel, 1968, This 
is highly sugaystive evidence of a close relationship 
between function and. glucose utilisation.
Since the classic paper of Sokol off et al, 1977, on the 
theory and methodology of the 2-deoxygluoose technique, 
many pharmacological studies have been published. These 
may be best exemplified by extensive work on the central 
dopaminergic system (brown and Volfson, 1978; McG\.illoch 
et al, 1979; McCulloch et al, 1980 a , ii, ; . Me Cul loch and
Kelly, 1981: h4Cullooh et al, 198? a.,bo), contral
noradrenergic system (Savaki et al, 1978; Cevaki et al,
1982 a,bo), central gabaergic influences (Kelly and. 
î'icCulloch, 1981; Kelly and McCulloch, 1982; Palacios et 
al, 1982) and anaesthetics such as barbiturates (Ingvar 
et al, 1980; Marnai et al, 1980; Gnkoloff et al, 1977),
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chloralose (Dudley et al, 1982) halothane (Shapiro et al,
1978), Ketamine (Lund et al, 1981) and chloral hydrate 
(Grome and McOulloch, 1983).
In these papers a general correlation has been found 
between previously published electrophysiological data 
and the effects of manipulation on local cerebral glucose 
utilisation. (see Sokoloff, 1982 for review)
However, they have provided a new perspective on the 
functional organisation of the brain and they have shown 
that there is a correlation between energy use and 
functional activity. What physiological parameter does 
glucose catabolism most reflect?
The physiological parameter most associated with nervous 
tissue is the propagation of electrical activity^ This 
process requires the constant maintenance of Na'^/K’^ 
gradients, which require the breakdown of adenosine 
triphosphate (ATP). Increased firing of the nerve should 
entail a concommitant increase in energy usso Since the 
oxidative metabolism of glucose is the sole provider of 
energy in the central nervous system under normal conditions 
(Sokoloff, I960), there should be a direct correlation 
between cellular activity and the glucose expended^
In vivo, there was a direct linear relationship between 
the frequency of the electrical spike activity in the 
superior cervical ganglion and glucose utilisation.
(Yarowsky et al, 1979). Furthermore, Mata et al, 1980, 
have used preparations of rat posterior pituitary, in 
vitro, to measure the effects of electrical stimulation 
on glucose utilisation. Electrical stimulation increased
ni4 bain which Inhibits Nr^/K^ Agussc but net snii
fT'HioosG ntil i sR.tion; an effect v/h’^ch w rs b^  cckci by
e
activity or vasopressin release. Since tTordmann, 1977 
has shown th'"'t of the posterior l'itiiator^ / is made
lU) of axon terminals, whi ch be canoe their high 
sn.r face-vo''nrne ratios wi^l have larger changes in 
ionoc concentration gradients for a given amount of 
spike activity, the changes in glucose utilisation 
observed by Mata et al, 1980 probably reflect the 
metabolic activity of axonal terminalso This is in 
agreement with the previous findings of (Kelly and 
McOullochp 1982, Kennedy et al, 1976; Schwartz et al, 
1979)) Therefor^ to summarise, local cerebral gincose 
utilisation seems to be directly linked via Ma^/K^ 
ATlase activity and electrical activity to function^
In the introduction to this thesis, it was stated that 
hny method purporting to define brain activity should 
ideally be able to make dynamic measurements of both 
local and integrated functiouo" It can be seen that 
the 2-deoxyglucose method does measure both local and 
integrated functiona.l activity, but what nrobleras are 
there in relation to its dynamic ogiali ties?
The areas of error associated wi th this techni.oue are 
timr resolution, ihe fact that t''crc is glucose - 6 - 
phosphatase activity in the rat a^d that there
are glycogen stores in the b^ 'aain ’vlh ch are capable of 
providing glucose for cellular use nuite separate to 
th^t of plasma-borne gl nooseo
In acmn^^ison to cleci.rophysioiogy, with its ah il i ty to
measure near-instantaneous changes in neuronal activity 
the forty-five minutes required to measure local 
cerebral glucose utilisation makes the technique 
at first sight extremely insensitive from the point 
of view of time resolution* This length of time (45 
minutes) is part of the experimental protocol of the 
2-deoxyglucose method as defined by Sokoloff et al, 1977 
and used in this study. The essence of the problem is 
that , Kg, and are all part of exponential terms in 
the operational equation of the method. (Fig* 5) This 
means that with increasing time these terms approach 
zero and, so the values of the rate constants do not 
have to be known exactly. Thus, it is possible to 
evaluate these constants in a separate series of animals 
(in this case the albino rat) and to use these numbers 
with the expectation that this will produce only a small 
error in the final measurement* This requires, however, 
that time resolution be sacrificed.
In relation to pharmalological studies this presents a 
problem since the effects of drugs (particularly at lower 
doses) may not be sustained throughout the forty-five 
minute period (e.g* the behavioural changes following 
the intravenous administration of serotonin agonists)*
This problem is not perhaps as serious as .may at first 
be thought, due to the fact that since the ^^G-2-deoxy- 
glucose is administered as a bolus intravenous injection, 
the majority of the integral will be made up of the area 
under the peak and rapidly falling phase of the curve*
Thus, the greatest contribution to tissue concentration
2 2 1
is made in the first ten minutes of the experiment* Thus, 
drugs producing an action for st least this length of time 
are capable of eliciting observable responses in the 
central nervous system* This in- no way totally negates 
the time resolution problem and probably accounts for 
the requirement of either a continuous input or large 
initial stimulation (in electrophysological terms) to 
allow effects to be measured* Time resolution still 
remains a problem*
As mentioned in the introduction, the 2-deoxyglucose 6 
phosphate formed by hexokinase is not a substrate for 
glucose-6-phosphate isomerase or glucose-6-phosphate 
dehydrogenase and therefor cannot be metabolised by the 
glycolytic or pentose phosphate pathway* However, it 
can be broken down by glucose-6-phosphatase to 2- 
deoxyglucose and glucose-6-phosphatase is present in 
the brain* This of course would have disasterous 
consequences for the method since it breaks the 
assumption that the 2 deoxyglucose-6-phosphate is 
trapped intracellularly*
Fortunately, this is not such a problem as it might 
seem since the activity of glucose-6-phosphate in the 
brain is low (Horton et al, 1973; Sols and Crane, 1954; 
Tower, 1958) and the loss of deoxyglucose-6-phosphatas^ 
by glucose -6- phosphatase activity is not significant 
during the first forty-Cive minutes after the bolus 
injection of ^^0-2 deoxyglucose (Sokoloff, 1979) o The 
effect is not negligible but becomes noticeable only after 
sixty minutes and substantial at ninety minutes.
(Sokoloff, 1982)*
Cellular elements in the brain contain depots of glycogen* 
Since this can provide glucose for energy production it is 
capable of oroducing an underestimation in the true rate 
of glucose utilisation as measured by the 2 deoxyglucose 
method* However, the concentration of glycogen is low and 
is incapable of sustaining the energy needs of the brain 
for more than three minutes (Mcllwain and Bachelard, 1971; 
Siesjo, 197B) o Nevertheless, it may be important in cases 
of sudden increase in glucose requirements (e*gu seizures 
or decreased glucose supply (e.g* ischaemia). Thus, 
glycogen stores do not present a major problem to the 
2-deoxyglucose method * Therefor, it can be assumed that 
this technique is able to measure functional changes in 
the central nervous system wi thin a reasonable degree of 
experimental accuracy*
As has already been stated the overall effect of the 
administration of 5-hydroxytryutamine (5HT) lysergic 
acid diethylamide (L8D), 5 methoxy-N,N-dimethyltryptamine 
(5MeO), quipazlne and chloropiuerazinyl pyrazine (d*?*?.) 
was to produce decreased levels o+ vlucose use in the 
T-pt ^'utral nervous system* Particularly, when v/e look 
cortical aweas, we s^e th-k the e ifects of Lyi),
fi'ieO, quipazine and C.r ' - or. .clue esc utilisation are 
0 ual its t T ve1 y co-ir or/^ b I e those of hPT itself, when in 
the presence of a monoamine oxidase inhibitor. 
Unfortunately, di^ferencos in the nreporations, route of 
administration ""nd serotonin's i nabi litv to cross the
blnocl-hroin barrier make it difficult to rnake p more 
meoninyM'ul comparison.
It con be seen that there is a distinct hierarchy of 
response, judged b" percentage change in glucose use, 
following the lower doses of the putative serotonin 
agonistso This pattern is almost identical for LSD, 
bMeO, Col'.?, and quipozineo In te is respect, LhB dons 
seem to be more potent tha.n the other three compounds and is 
capable of p^'oducing significant decreases in 
glucose utilisation at microgra.mme dose levels*
These changes in glucose use are in keeping with much 
of the available elec trophysiological d ata. showing that 
5HT, LSD and 5MeO produced decreases in the activity of 
spontaneously filing cells in various areas of the rat 
brain. (Bloom et al, 1972; de llontagriy and Arhaia.nban, 
1977; Dray et ai , 1976; Haiyler find Agha j an ion, 197^: 
Sastry and Phyllis, oegal, 1975; 01pe and Koella, 1977;
Wang and Aghajanian, 1977)* Furthermore, these similarities 
were underlined by the actions of LSD, ^MeO, C.P.P* and 
quipazlne on behaviour and cardiovascular parameters*
The behavioural effects of these compounds hove been 
extensively studied. (Clineschmidt, 1077; Gessner and 
Page, 1962; Grahfime-Smi fch, 1971a; Green et al, 1976; 
Jacobs, 1976; blovitei- et al, 1978)* This behaviour 
could not be, ot least by crude observation alone, be 
differentiated f r o m  the bohavioim^al syndrome v/hich <^ccurs 
in rats following treatment with a monoamine oxidase 
inhibitor and L-tryptophan. (Hess and Doephncr, 1961;
Grahame-Smith, 1971). The one part of the syndrome which 
did not occur was hyperpyrexia. This was due to a 
decision made before the commencement of these studies 
to control the core body temperature of the rats at all 
times and therefore the temperature was kept within the 
limits of 37.0 + 0*5^0 (mean + S.D.)
Similarly, with the effects of L.S.D., 5MeO, G.P.P. and 
quipazine on blood pressure and heart rate, it could 
rightly be claimed that as the drugs were administered 
intravenously these effects are probably direct actions 
of these drugs on the cardiovasculature. However, the 
central administration of 5HT produced hypertension 
(Antonaccio and Cote, 1976; Krstic and Djurkovic, 1976; 
Lambert et al, 1975; Lambert et al, 1978). It has also 
been postulated that 5HT and G.P.P. may produce their 
cardiovascular effects by a central action which reduces 
sympathetic output (Antonaccio and Gote, 1976; Blatt et 
al, 1979)0 Therefore, some of the cardiovascular effects, 
produced by these putative serotonin agonists, are probably 
due to their central actions.
Although the majority of affected brain areas displayed 
similar changes in glucose use following these compounds, 
there can be little doubt that there were distinct 
differences in the patterns of cerebral response produced 
by the agonists containing an indoleamine moeity (L.S.D. and 
5MeO) and those having a piperazine-containing structure.
Two major differences could be seen in the responses 
produced by these structurally differing serotonin agonists. 
In the extrapyramidal areas there was a biphasic response
following G.P.P. and quipazine whereas LSD and 5Meo 
produced dose-dependant decreases in glucose utilisation*
In fact, the differences were even more subtle. The 
'indoleamine' agonists produced an overall decrease in 
the four areas of the caudate nucleus measured, the globus 
pallidus and the substantia nigra* Quipazine and G.P.P. 
however, had no significant effects on the dorsolateral 
and central portions of the caudate nucleus, at any dose 
used and high doses of quipazine produced increases only 
in the ventromedial caudate nucleus, the globus pallidus 
and the pars reticulata of the substantia nigra*
As has been previously discussed (Chapters IV and V of 
this thesis), these effects may be due to a direct action 
of the drugs on these structures* The effects of LSD 
and 5MeO, and G.P.P. and quipazine (at low doses) would 
be in keeping with electrophysiological data describing 
the mainly inhibitory responses of striatal and nigral 
neurones to microiontophoretic serotonin administration* 
(Dray et al, 1976; Miller et al, 1975; Olpe and Keolla, 
1977)
Despite the findings of Van der Maelen et al, 1979, of 
excitatory striatal responses to serotonin administration 
it is the discrete localisation of the effects of quipazine 
in the caudate nucleus that is of so much interest. In this 
respect they correlate very well with the topographical 
arrangement of serotonergic fibers to the caudate nucleus 
which are most dense in the ventromedial portion (Ternaux 
et al, 1977) and the biochemical data which shows that 
quipazine produces its biggest effect on acetylcholine 
turnover in this region of the caudate nucleus* (Euvrard
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et al, 1977; Guyenet et al, 1977)*
An sa. Tented in Cheater V of this thesis, the increases 
in striatal and nigral glncose use may be due to the 
fact that only at i;he highest doses did ouinazine and 
C.h.T. produce decreased glucose utilisation in the 
sensory-notoT' cortex, theis, perhaps producing a dis_ 
inhibition of that area of the caudate nucleus. However, 
LSD and HlïeO both pmriucej significant decreases in 
sensory-motor cortex without inducing increases in 
eXtrar-yram±da 1 reas *
In their effects cn diencephalic areas too, piperazine 
and indoleamine-containing compounds had differing effects 
Whereas, LÜD and 5MeO generally produced dose-dependant 
decreases in glucose use, C.d-.P. and ciuipazine produced 
discrete increases in glucose use in the nucleus reunions 
of the midline thalamus, the zona incerta, the ueriven- 
tr i cular nucleus and additionally G.P.I. increased the 
functional activity of the lateral habenular nucleus *
As stated previously (Chapters IV and V) th.ese stmuTures 
all receive serotoninergic innervation arisinv from the 
raphe nuclei. (Azmitia and 8 caul, 1 9 7 9 :  Gtei.nbusch, 1981 )
This does not explain why LCD and GMeO decrease, o^  ^ leave 
unaffooted , the rate of glucose use in these st'^uctures 
whil-^ cuipozine and G w  .1'. m^oduce the orrosite effect*
In this content it should be notad that the nerinheral 
administration of '^sychoaoti ve drurs wil ] nr^duce chun^-es 
not only in the areas of the brain where they bind to 
recentors, but alsa in areas which are anat^mie^iiy 
connected in the nrima site ''■'f ^■^w.ronse; in a + bf^ r
word s rn intevup.ted response v/i? 1 develop .
Thus, there rre reciprocal rethv/ays between the nucleus 
reunl.ens and the zona incerta (Herkenham, 1978; Ricardo, 
1981), the zono incerta sends fibers to the globus uallidus 
and reçoives them from the visually-related areas; the 
ventrolateral geniculate body and superior colliculus 
(Ricardo, 1981)* The nucleus reunions also sends fibers 
to the globus paJ lidus and caudate nucleus (Nauta and 
Mehler, 1966; Rowell and Cov/a.n, 1996) as well as to the 
hippocampus (Herkenham, 1978) and receives afferent fibers 
from the nucleus sccunibens which also has connections with 
the globus pallidus (Rowell and Leman, 1976; Williams et 
a.i., 1977), ^brth^rmore, the ventral tegmental area sends
fibers to the ventromedial caudate nucleus, the nucleus 
accumbens, nu.cleus reunions, zona incerta, lateral 
habenular nucleus and the dorsal and median raphe nucleus 
(Reckstead et al, 1979).
As can be seen from tables 5, 7, 9 and 11, the anatomical
areas mentioned above are all affected by the putative
serotonin agonists* That they are anatomically and, we
must presume, functionally connected leads to an almost
endless series of possibilities as to the initial site of
action of those drugs* Thus it might seem reasonable to
suggest that these differences are dnp, not simply to an
effect of tnese driu;s on the a^eas showing increased
glucose utilisation, but due to the production of an
integrated T’esnonse in the central nervous svstem. With 
-
the eynorimontal model which I have used in these series 
of cxreriments, I cannot define the nrimawy site of action
but can iden’.IM'y areas of the bra i.n which are sensitive 
to the ’-^ er ich *"a ■> adm inis tz'a t inn of t  "C s(? drugs*.
This being the case, it is still rea.sona.b1 e to a s su me 
that t^e actions of these agonists are due to their 
interaction with physiological receptor mechanisms* 
bh^t evi d r.nce , if any, is there that there are differences 
in the way indoleamine - and piperazine-containing 
serotonin agonists interact with serotonin receptors?
beh.aviou'ral d'">ta on the effects of these da’ugs in 
producing myci onus in the guinea, pig, (jenner et al 
I98O; buscombe et al, 1982), showed ih^t piperazine- 
containing serotonin agonists rarely nroduced myoclonic 
jerkin/" in guinea-pigs, whilst serotonin agonists 
possessing ^n indole nucleus- indoced dose-dependant 
myocl onus. ho behavioural differences coul.d be ascertained 
in tris nresent series of exreriments but it has been 
shown that the behavioural syndrome in vu i.nea -nigs aftar 
ccptupl serotoninergic activation is 'simpler' in na.ture 
than that ppoduced in the rat* (Chadwick et al, 1978)*
There î s also some differentiation between these two
sets of putative serotonin agonists with regard to their
interactions with serotonin recentors* Thus, whilst fMeO
and kf'T) stimulated fhT-sens i t i ve ah onyln te cycle sa in
youn*- rats (Neman et ai , 1976 ; Von hun.oen et al, 19'1'^ b)
pninaz ine < nd. f  h- , ’'-h a ' t'linn oh r nt.f-'nt d h r  .1 o c 0 r  c> of  
z
H-5HT neither stimulated nor inhibited this mechanism 
(Fuller et al, 1978; Nelson et'al, 1980a)° Furthermore, 
the nresence of 'uanosine tri nhosrhate fCTP) reduced the
z
potency of 5MeO displacement of H-spiroperidol but did
not affect the actions of quipazine. (Hamon et al, 1980)
Since Mallat and Hamon, 1982 a,b. showed that at least 
z
some of H-5HT binding may be associated with 5HT-sensitive 
adenylate cyclase, it is very tempting to hypothesise a 
differential effect of these compounds on different classes 
of 5HT receptor leading to the production of different but 
overlapping patterns of physiological response.
One of the major criticisms which might be leveled at the 
data presented is that the drugs may be acting on receptors 
other than serotonergic, . There is evidence that LSD,
5MeO and quipazine all produce changes which might be 
interpreted as an affect on dopaminergic systems 
(Grabowska et al, 1974; Green and Grahame-Smith, 1974;
Von Hungen et al, 1974), LSD binds to dopamine 
receptors. (Whitaker and Seernan 1979)
However, there are several factors which must be taken 
into account. Firstly, there is the behavioural and 
biochemical data showing an interaction between drugs 
acting on the central serotonergic and dopaminergic systems, 
(Jacobs, 1974; Samanin and Garattini, 1975; Waddington 
and Crow, 1980; Weiner et al, 1975)° Secondly, there 
are well defined connections between the raphe nuclei 
and the dopaminergic cell bodies of the substantia nigra 
(Azmitia and Segal, 1979; Steinbusch, 1981) and these 
connections are reciprocal (Pasquier et al, 1977; Sakai 
et al, 1977). Thirdly, whereas the dose-dependant actions 
of LSD on local cerebral glucose utilisation in the conscious 
rat are similar to those given in a previous investigation
(Shinohara et al, 1976), the actions of serotonin-mimetic 
drugs in the present studies are in no way similar to the 
actions of apomorphine on cerebral function (McCulloch et 
al, 1982a).
The data given here, suggests that although serotonin 
agonists and antagonists may bind to dopamine receptors, 
in vitro, their major action in vivo is probably via 
serotonin receptors.
Before discussing the actions of methysergide, metergoline 
and cyproheptadine, it would perhaps be useful to define 
what we mean by the word 'antagonist'. In pharmacological 
terms, this is a compound which blocks the action of the 
agonist by binding to the receptor. The receptor-antag- 
onist complex has nn intrinsic physiological action. 
Methysergide and metergoline had no significant effects 
on local cerebral glucose utilisation at the lowest doses 
used (ioGo 5 mg/kg and 0.3 mg/kg respectively) but these 
doses did not appreciably inhibit the actions of the serot­
onin agonists on behaviour or the cardiovasculature* The 
highest doses of these compounds block actions of 
serotonin agonists on behaviour and the cardiovasculature 
without having any intrinsic effects* Thus, in terms of 
behaviour, heart rate and blood pressure, the putative 
serotonin agonists, methysergide and metergoline fit 
the definition of a serotonin antagonist*
However, in terms of their actions on local cerebral 
glucose utilisation, there can be no doubt that they 
produce changes, in their own right. These effects concur
with the electrophysiological data of Haigler and 
Aghajanian, 1974. Furthermore, methysergide, metergoline 
and cyproheptadine all decreased glucose utilisation in 
a manner which was qualitatively similar to the putative 
serotonin agonists. Closer attention to the data shows 
that methysergide and metergoline produced a similar 
pattern of cerebral response which is different from 
that produced by cyproheptadine* (see Chapter 6 of this 
thesis).
However, electrophysiological data shows that 
metergoline and methysergide can block some of the effects 
of serotonin (Sastry and Phillis, 1977; Segal, 1975;
Segal, 1976), particularly the excitatory effects* (McCall 
and Aghajanian, 1979; Van der Maelen and Aghajanian, 1980) 
Interestingly enough, it has been suggested, based on 
in vitro data, that serotonin agonists and antagonists 
bind to different serotonin binding sites or different 
forms of the same receptor (Bennet and Snyder, 1976; 
Enjalbert et al, 1978; Nelson et al, 1978; Nelson et 
al, 1979).
These data would at least suggest that methysergide and 
metergoline have the capability of inhibiting the actions 
of serotonin at some serotonin receptors in the rat central 
nervous system.
As mentioned above, methysergide and metergoline blocked 
the behavioural and cardiovascular effects of LSD, 5MeO, 
C.P.P. and quipazine. The central effects of these
<-
combinations are highly complexo
Methysergide and metergoline block some but not all the 
actions of the putative serotonin agonists. The most 
notable inhibition was the total blockade (and in one 
case reversal) of the increases in local cerebral glucose 
utilisation produced by the piperazine-containing serotonin 
agonistso Methysergide at a dose of 15mg/kg seemed to be 
more potent in this respect (see Chapters 7 and B of this 
thesis). Perhaps the least expected result was the 
potentiation of some of the actions of the putative 
serotonin agonists by methysergide and metergoline□
In this respect, metergoline (3mg/kg) seemed to be able 
to produce this action more frequently than methysergide 
(Chapters 7 and 8 of this thesis)a
In a qualitative sense, these data support the previously 
published electrophysiological information which showed 
that methysergide and metergoline block excitatory 
responses to serotonin (McCall and Aghajanian, 1979; Van 
der Maelen, 1980), some of the inhibitory responses 
(Sastry and Phillis; Segal, 1976) and enhances or leaves 
unaffected other serotonin-induced inhibitory responses 
(Haigler and Aghajanian, 1974)o This does not, however, 
explain why this should occur* One interpretation, is that 
metergoline and methysergide are partial agonists* In this 
respect there is evidence that L.S.D. is a partial antagonist 
(Anden et al, 1968; Aghajanian and Wang, 1978). Since partial 
agonism is usually a dose-dependant phenomenon, one might
expect a biphasic dose-response curve. In the dose range 
used, the dose-response curve to LSD in the majority of 
cerebral structures is raonophasic.
Only the high doses of methysergide and metergoline had 
any effect, per se, on cerebral function. Furthermore, 
methysergide blocks or attenuates many of the responses 
to 5MeO but does not produce any potentiation of 5MeO* 
Perhaps even higher doses of methysergide and metergoline 
might produce a 'cleaner' response. Further experiments 
would be required to elucidate this point*
This would not explain why these compounds are consistantly 
able to produce marked attenuation of the behavioural 
syndrome produced by putative serotonin agonists. (Balsara 
et al, 1979; Chadwick et al,, 1978; Clineschmidt and Lotti, 
1974; Green et al, 1981 inter alia). One possible explan­
ation is based on the work of Jacobs and Klemfuss, 1975, 
who found that the complete 'serotonergic behavioural 
syndrome' (Jacobs, 1976; Sloviter et al, 1978), produced 
by L-tryptophan and monoamine oxidase inhibition could be 
elicited following the aspiration of the entire neostriatum. 
More surprisingly, a transection of the brain posterior to 
the red nucleus, substantia nigra and midbrain raphe nuclei 
left the behavioural syndrome intact. These data suggested 
that the response was mediated by pons, medulla and spinal 
cord.
This further suggests that either the serotonin agonist 
action can be blocked due to differences in the serotonin 
receptors in these areas as opposed to the forebrain or
that the physiological processes which they mediate are 
simpler than those in the forehrain and therefore can 
more easily be blocked*
Even if this is the case, in the intact animal the fore­
brain and particularly neostriatum will reflect in its 
functional patterns not only the actions of these drugs 
in the forebrain itself, but also information from within 
and without the central nervous system* It is, in my 
opinion, this that we are detecting in the changes in 
local cerebral glucose utilisation following the admin­
istration of both putative serotonin agonists and ant­
agonists - the central integration of all the effects of 
these drugs.
As was mentioned above, serotonin agonists and antagonists 
may well show preference for different serotonin receptors 
in the central nervous system (Bennet and Snyder, 1976; 
Enjalbert et al, 1978; Nelson et al, 1978; Nelson et al,
1979). If this is the case, then from the data presented 
here the resultant physiological response is different from 
that produced by either the agonist or antagonist alone*
The Relevance of These Studies and Future Studies 
The serotonin agonists used in this thesis can be classified 
not only on the basis of their structural properties but 
also on their effects in the human* Lysergic acid 
diethylamide is a powerful hallucinogen (Hoffer, 1965, for 
review), as is 5 methoxy-N,N-dimethyltryptamine, which is 
a major component of some South American psychoactive snuffs
(Agurell et al, 1968; Agurell et al, 1969). This latter 
compound is of particular interest since some investigators 
have claimed to be able to detect the presence of this 
compound in the body fluids of schizophrenic patients 
(Heller et al, 1970; Narasimhachari et al, 1971) 
which is probably due to 'abnormal méthylation' (Banerjee 
and Snyder, 1973; Mandell and Walker, 1974).
On the other hand quipazine and chloropiperazinylpyrazine 
have more in common structurally with tricyclic anti- 
depressants* Little information on the actions of 
chloropiperazinylpyrazine on Man is avllable* However, 
quipazine, which has been shown to have many pharmacological 
actions in common with tricyclic antidepressants in rodents 
(Rodriguez and Pardo, 1971),. produced no psychiatric 
abnormalities when administered to Man (Parati et al, 
1980).
The information given in this thesis, although carried out 
on rats, reinforces this dichotomy of psychoactive effects 
in man. In terms of the blockade of these effects by two 
putative central serotonin antagonists, the problems facing 
the neuropharmacologist remain* If all the effects of 
serotonin-mimetic drugs can be blocked by a single compound, 
the evidence would suggest that this compound still has to 
be found* In this sense perhaps the most intriguing finding 
of this work has been that the patterns of cerebral response 
produced by serotonin agonists, antagonists and the 
combination of the two were different* This does not 
fit in with the 'classical' pharmacological view of agonist-
antagonist interactions* More work is required to unravel 
the problem*
The future continuation of this work could include two 
approaches* First, selective lesioning of the midbrain 
raphe nuclei and areas of the brain which have been shown 
to be 'sensitive' to the peripheral administration of the 
serotonin agonists* Sgcond, the chronic implantation of 
cannulae into cerebral structures, shown to be responsive 
in this present work, for the local administration of 
serotonin-active compounds*
It is hoped that while this thesis may not have unravelled 
fully the effects of serotonin agonists and antagonists on 
cerebral function, it has uncovered some new facets of the 
actions of these drugs on specific cerebral systems* 




The method by which the local cerebral glucose 
utilisation data is obtained has already been described 
in the Methods section* However, to completely understand 
the process by which the data are derived, it is necessary 
to go into the arithmetical manipulations which are under­
taken.
The example given below is real data obtained from a 
saline control animal (Quip 8*)*
Plasma data: Following the measurement of the plasma
concentration by liquid scintillation analysis (Phillips: 
PV/4540) and plasma glucose by semi-automated analysis 































Kill time: 45.12 min.
This data is entered into a computer (Cromenco System 
Three) and, using a programme devised by Dr. W. Angerson, 
and given that we use the following rate constants, we can 
calculate the final deoxyglucose tissue concentration and 
final plasma integral in grey and white matter:-









Where K^, and are the rate constants for the
transport of deoxyglucose into the brain, from brain
back to plasma and the phosphorylation of deoxyglucose
by hexokinase, respectively, is the half-life of
2
^^0 deoxyglucose in the percursor pool and is described 
as logg2 / (Kg + K^) (Sokoloff, 1977).
Grey Matter White Matter
Final tissue DG 30 28
concentration (nOi/g)
Final plasma Integral 700 680
(nCi/umol)
We can go no further until after the x-ray films have been 
exposed to the tissue sections for seven d ays and have been 
developed *
Densitometry : The first readings are made on the
images of the plastic standards. The computer
then works out the best fit between the optical density 
(OD) and the known ^^G concentration..









good fit, so we can proceed. All the optical
densities of the structures of interest will be compared to 
these standards to obtain the ^^0 tissue concentration.
Thus, using the operational equation of Sokoloff, as 
described in the Methods section, we can work out, for 
example, the rate of glucose use by layer IV of the auditory 
cortex* The optical density is 1*71 which gives a tissue 
concentration of 572 nCi/g* Thus:-
R — Total concentration - DG- remaining in tissue
 ^ Lumped constant x corrected integrated plasma specific
activity.
_ 572 - 30
0.49 X 700
1*58 umols/g/min.
By convention the answer is normally expressed as 
umol/lOOg/min* Thus, the rate of glucose use in auditory 
cortex is 158 umol/lOOg/min, and in this manner the local 







Auditory Cortex 1*71 572 150







Corpus callosum 0.94 120 28
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ADDENDUM
A CONSIDERATION OF THE SEROTONERGIC INTERACTIONS WITH NON­
NEURONAL ELEMENTS: POSSIBLE INFLUENCES ON THE MEASUREMENT
OF GLUCOSE UTILISATION AS MEASURED BY THE 2-DE0XYGLUC05E
TECHNIQUE.
General Comments: In each of the anatomical areas measured in
this study a variety of cellular elements are present. In terms 
of brain function (as represented by the transfer of electrical 
information) the neurones could be considered to be the most 
important. Since, the study of pharmacology in the central 
nervous system is essentially bound up with acquiring a 
knowledge of the interactions of drugs with receptors on 
neurones and thus their ability to facilitate or attenuate the 
process of information transmission, it is these processes 
which are of greatest interest.
The method described in this thesis measures glucose 
utilisation in an area of tissue and so it is a mean of the 
relative contributions of neuronal and non-neuronal elements.
The results presented in this thesis would suggest that in 
saline control rats the levels of glucose utilisation obtained 
remains relatively stable i.e. the relative proportions of 
glucose used by neurones and glia do not vary greatly^
However, the use of this method to assess the potency of 
serotonin agonists and antagonists raised a number of questions. 
First, is there evidence of possible differential actions by 
serotonin mimetic compounds on neurones and glia? Second, 
what effects would these interactions have on the final 
measurement of glucose utilisation?
Evidence for Serotonin Receptors on Neurones and Glia
Serotonin receptors in the brain have been studied using a 
number of radioactive ligands (Sennet and Synder, 1976; Pillion 
et al., 1978; Nelson et al., 1980). These authors and others 
have produced a classification of two types of serotonin 
receptors based on these ligand-binding experiments. The first
3
receptor, termed 5HT^, has a high affinity for H-5HT, which 
appears to be dependent on the binding of guanosine triphosphate 
(GoT oPo) and at least part of this population may be the 
recognition site for a serotonin - sensitive adenylate cyclase. 
The second sub-group of receptors, SHT^j have a higher affinity
3 . 3
for H-spiroperidol than H-5HT. These receptors do not appear 
to require GTP for binding nor do they correspond with recog­
nitions sites for 5HT-sensitive adenylate cyclase (see Pillion, 
1983; Nelson, 1983 for reviews). They do, however, appear to 
correlate with those receptors which are involved in certain 
behavioural responses which have been associated with changes 
in the activity of the central serotonin system (Leysen et al,, 
1981), It has, therefore, been suggested that BHTg sites 
mediate the "excitatory" responses to serotonin; such as 
tryptamine-induced seizures (Leysen et al,, 1981) and 5-hydroxy- 
tryptophan-induced head-twitches in mice (Peroutka et al., 1981). 
On this basis it has been suggested that the majority of BHT^ 
receptors are probably post-synaptic and neuronal.
There is good evidence that the 5HT^ population is hetero­
geneous (Pillion et al,, 1976; Nelson et al,, 1980; Peroutka 
and Snyder, 1979). Pillion et al., 1979 showed that the high- 
affinity binding corresponded to postsynaptic neuronal sites.
The same group suggested that the low affinity binding sites
correspond to a glial component. At the same time it was 
observed that two types of adenylate cyclase activity which 
were sensitive to serotonin were present in homogenates of 
various brain regions (Pillion et al., 1979). It was further 
shown in these studies that purified synaptic membranes 
contained only the high affinity type of adenylate cyclase 
activity. This was postulated as post-synaptic and 
neuronal in character (see Pillion, 1983 for review).
Using glial cell membrane preparations and isolated from 
rat striatum and glial cell lines grown in culture, it was 
observed that the activation of 5HT sensitive adenylate cyclase 
corresponded to a low apparent affinity constant (Pillion,
1983), It was, therefore, suggested that the low affinity 5HT^ 
sites are related to 5HT-sensitive adenylate cyclase activity 
and that this is present on glia rather than neurones. However, 
a definitive connections between these sites awaits a time when 
the solubilisation and reconstitution of these receptors is 
achieved.
Implications for the 2-Deoxyqlucose Method
The above evidence suggests that serotoninmimetic agents 
may well produce changes in glial cell function via, receptors 
linked to adenylate cyclase. Such a differential effect by 
serotonin-like agents on glial cells and neurones might well be 
postulated to have a marked effect on the relative amounts of 
glucose used by neurones and glia and, therefore, on the final 
meaned glucose utilisation value.
Can the ratio of glial to neuronal glucose utilisation be 
estimated?
The ratio of numbers of glia/neurones has been estimated 
as 0,5 in 100 days old rats (Brizee et al., 1964). This is in 
agreement with the ratio of the relative volumes of perikarya 
of neurones and glia which was also 0,5 (Ramon-Moliner, 1961), 
Furthermore, estimates of the surface areas of the dendrites 
of giant cells in the reticular formation suggest that the 
total volume of these processes may be 5 times greater than that 
of their cell bodies (Peters et al., 1970), Thus, the total 
volume of neurones and their extensions is probably appreciably 
higher than that of glial cells.
Several groups have estimated that neurones are responsible 
for between 75^ and 95^'of the oxygen consumption in the cortex 
(Elliot and Heller, 1957; Korey and Orchen, 1959; Hess, 1961). 
Furthermore, when the relative volumes of glia and neurones 
are taken into account, it can be shown that the average neuron 
should have a respiratory rate 16-50 times that of the average 
cortical neuroglial cells (Friede, 1954), It can also be 
estimated that even a doubling of the non-neuronal respiratory 
rate could only reduce the proportion of oxygen used by neurons 
by approximately 4^ (Allen, 1957),
This information is in keeping with the data of Yarowsky 
et al., 1979 who showed that there was a direct linear relation­
ship between the frequency of electrical spike activity in the 
superior cervical ganglion and glucose utilisation. Also,
Mata et al., 1980 have observed that preparations of rat 
posterior pituitary, in vitro, show a dose correlation between 
Na^ /K"*" ATPase activity and glucose utilisation as measured by 
the 2-deoxyglucose technique. Because of the high density of 
axon terminals present in this tissue and the consequent high
ionic concentration gradients for a given amount of spike 
activity (Hardmann, 1965), Mata et al., 1980 concluded that 
the changes in glucose utilisation observed probably reflect 
the metabolic activity of axonal terminals.
Indirect evidence has also come from the work of Frey and 
Agranoff, 1983 who recently showed that the administration of 
barbiturate to rats with ibotenic acid lesions (a toxin which 
destroys neurones but leaves non-neuronal cells and blood 
vessels intact) had marked depressive effects on 2 deoxyglucose 
uptake in all areas of the brain except in the lesioned area. 
They suggested that the surviving non-neuronal elements formed 
a metabolically stable population in comparison to neurones.
In conclusion, there is evidence that glial cells have 
serotonin receptors some of which are probably related to 
serotonin-sensitive adenylate cyclase activity. This allows 
the possibility that neuronal and non-neuronal elements may 
be affected differentially by serotonin and serotonin-like 
compounds. However, although the glial component of total 
oxygen and glucose consumption is by no means negligible, it 
is smaller and apparently more stable than that of neurones. 
Therefore, it may be concluded that while a portion of the 
glucose utilisation effects seen in this thesis, following the 
administration of serotonin agonists and antagonists, were 
produced by the actions of these compounds on non-neuronal 
elements, the greater proportion of change in glucose 
utilisation probably reflect changes in neuronal metabolic 
activity.
An Estimation of the Maximum and Minimum Changes in Local 
Cerebral Glucose Utilisation
Siesjo (1978) states that ".....  generalised seizures
represent the most intense cerebral activity known......",
This statement is emphasised by the findings of Meldrum and 
Nilsson, 1976 who showed that the cerebral metabolic rate for 
oxygen use (CMRO^) increased by 250% within the first minute 
of bicuculline-induced status epilepticus in rats. There is 
evidence too that cerebral glucose utilisation exceeds oxygen 
consumption. It was shown that bicuculline-induced seizures 
increased CMRO^ by 267% but they increase glucose consumption 
by 400%.
At the other end of the scale, barbiturates produced a 
dose-dependent reduction in the level of consciousness and 
metabolic rate. This was originally shown by Kety et al.,
1947-48, who obtained a 45% reduction in CMRD^ during deep 
thiopental induced anaesthesia in humans. Of perhaps most 
interest are the observations of Crane et al., 1978, showing 
that in the rat the maximum reduction of glucose utilisation 
following pentobarbital administration was approximately 60%, 
Higher doses produced no further decrease in glucose utili­
sation, Thus, they postulated that there was a basal rate 
of glucose utilisation which was insensitive to barbiturate 
administration.
In the light of the inverse correlations between barbiturate 
dose and consciousness and barbiturate dose and electorial 
activity (Morzorati and Barnes, 1977), it is tempting to 
speculate whether the basal metabolic rate measured in the 
study of Crane et al., 1978 was due at least in part to the
metabolically more stable glial cells (see afore-mentioned).
In conclusion, the maximum and minimum glucose utilisation 
values which might be expected would lie between -60% and + 
400%. The results described in this study fall within this 
range and are therefore worthy of consideration.
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